{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "38412455-78c3-4c9c-8c5d-e40fcfcf948c",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "sys.path.append(os.getcwd()+\"/../..\")\n",
    "from src import paths\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "import torch\n",
    "\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "from sklearn.metrics import f1_score, recall_score, precision_score, classification_report\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "238d4c4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_results(filename:str, labels:str, load_line:bool = False, load_outlines:bool = False):\n",
    "    \"\"\" \n",
    "    Load results from a file and return a pandas dataframe with the results.\n",
    "\n",
    "    Args:\n",
    "        filename (str): The name of the file to load.\n",
    "        labels (str): The name of the file containing the labels.\n",
    "        load_line (bool, optional): If True, the function will expect a line labelled dataset and return the aggregated results per rid.\n",
    "        load_outlines (bool, optional): If True, the function will expect the output of an outlines prompt (no hidden states and model answers are labels)\n",
    "\n",
    "    Returns:\n",
    "        pd.DataFrame: A pandas dataframe with the results.\n",
    "\n",
    "    \"\"\"\n",
    "    results = torch.load(paths.RESULTS_PATH/\"ms-diag\"/filename, map_location=torch.device('cpu'))\n",
    "    labels = torch.load(paths.RESULTS_PATH/\"ms-diag\"/labels, map_location=torch.device('cpu'))\n",
    "\n",
    "    output = {\"model_answers\": results.pop(\"model_answers\")}\n",
    "\n",
    "    if not load_outlines:\n",
    "        \n",
    "        # Get prediction through cosine similarity\n",
    "        last_hidden_states = results.pop(\"last_hidden_states\")\n",
    "        last_hidden_states = last_hidden_states.cpu()\n",
    "        preds = get_prediction(last_hidden_states, labels_hs=labels[1], label_names=labels[0])\n",
    "\n",
    "        # If rag\n",
    "        if \"rag\" in filename:\n",
    "            output[\"model_answers_mapped\"] = preds + [\"no information found\" for _ in range(len(output[\"model_answers\"])-len(preds))]\n",
    "        else:\n",
    "            output[\"model_answers_mapped\"] = preds\n",
    "    \n",
    "    # Map from string answer to int\n",
    "    label2id = {'primär progrediente Multiple Sklerose': 0,\n",
    "            'sekundär progrediente Multiple Sklerose': 2,\n",
    "            'schubförmige remittierende Multiple Sklerose': 1,\n",
    "            'other': 3,\n",
    "            'no information found': 3}\n",
    "    \n",
    "    if load_outlines:\n",
    "        key = \"model_answers\"\n",
    "    else:\n",
    "        key = \"model_answers_mapped\"\n",
    "    \n",
    "    output[\"preds\"] = [label2id[i] for i in output[key]]\n",
    "    output[\"exact_match\"] = [res in label2id.keys() for res in output[\"model_answers\"]]\n",
    "\n",
    "    output[\"labels\"] = results[\"labels\"]\n",
    "    output[\"rid\"] = results[\"rid\"]\n",
    "    output[\"text\"] = results[\"text\"]\n",
    "\n",
    "    if \"whole_prompt\" in results.keys():\n",
    "        whole_prompt = results[\"whole_prompt\"]\n",
    "        if \"rag\" in filename:\n",
    "            output[\"whole_prompt\"] = whole_prompt + [\"no information found\" for _ in range(len(output[\"model_answers\"])-len(whole_prompt))]\n",
    "        else:\n",
    "            output[\"whole_prompt\"] = whole_prompt\n",
    "    \n",
    "    df = pd.DataFrame(output)\n",
    "\n",
    "    if load_line:\n",
    "        return convert_line2report(df, filename)\n",
    "    else:\n",
    "        return df\n",
    "\n",
    "def get_prediction(hs: torch.Tensor, labels_hs: torch.Tensor, label_names: list):\n",
    "    \"\"\" \n",
    "    Get the prediction for a given hidden state and labels.\n",
    "\n",
    "    Args:\n",
    "        hs (torch.Tensor): The hidden state to use for prediction. Shape (n_samples, n_features).\n",
    "        labels_hs (torch.Tensor): The hidden states of the labels. Shape (n_labels, n_features).\n",
    "        label_names (list): The names of the labels. The order of the names should match the order of the hs-labels in dim 0.\n",
    "\n",
    "    Returns:\n",
    "        torch.Tensor: The predicted labels.\n",
    "\n",
    "    \"\"\"\n",
    "    answer_idx = np.argmax(cosine_similarity(hs, labels_hs), axis=1)\n",
    "    model_answer = [label_names[i] for i in answer_idx]\n",
    "    return model_answer\n",
    "\n",
    "def convert_line2report(rids:list[str], preds:list[int])->list[int]:\n",
    "    \"\"\" \n",
    "    Aggregeates the results of a line labelled dataset in a majority vote fashion.\n",
    "\n",
    "    Args:\n",
    "        rids (list[str]): The rids of the samples.\n",
    "        preds (list[int]): The predictions of the samples.\n",
    "\n",
    "    Returns:\n",
    "        list[int]: The aggregated predictions.\n",
    "        \n",
    "    \"\"\"\n",
    "    df = pd.DataFrame({\"rid\":rids, \"preds\":preds})\n",
    "\n",
    "    # If len value counts >1 and value counts[0] is 3, then majority vote is value counts[1]\n",
    "    results = []\n",
    "    rid = []\n",
    "    for _df in df.groupby(\"rid\"):\n",
    "        if _df[1].preds.value_counts().shape[0] > 1 and _df[1].preds.value_counts().iloc[0] == 3:\n",
    "            result = df.loc[df.rid == _df[0], \"preds\"] = _df[1].preds.value_counts().index[1]\n",
    "        else:\n",
    "            result = df.loc[df.rid == _df[0], \"preds\"] = _df[1].preds.value_counts().index[0]\n",
    "        results.append(result)\n",
    "        rid.append(_df[0])\n",
    "    return result\n",
    "\n",
    "\n",
    "def summarize_performance(files: list[str], *args, **kwargs):\n",
    "\n",
    "    \"\"\" \n",
    "    Summarizes the performance of a given strategy (Base, RAG, Outlines) for all prompting strategies.\n",
    "\n",
    "    Args:\n",
    "        files (list[str]): The files to summarize.\n",
    "        *args: Variable length argument list.\n",
    "        **kwargs: Arbitrary keyword arguments.\n",
    "\n",
    "    Returns:\n",
    "        pd.DataFrame: A pandas dataframe with the summarized results.\n",
    "\n",
    "    \"\"\"\n",
    "    dfs = []\n",
    "    for filename in files:\n",
    "        strategies = [\"zero_shot_vanilla\", \"zero_shot_instruction\", \"few_shot_vanilla\", \"few_shot_instruction\"]\n",
    "        \n",
    "        # Set strategy name to whatever is found in the filename\n",
    "        for strategy in strategies:\n",
    "            if strategy in filename:\n",
    "                break\n",
    "\n",
    "        results = load_results(filename=filename, labels=kwargs[\"labels\"], load_line=kwargs[\"load_line\"], load_outlines=kwargs[\"load_outlines\"])\n",
    "\n",
    "        # Target names\n",
    "        metric_dict = classification_report(y_true=results[\"labels\"], y_pred=results[\"preds\"], output_dict=True)\n",
    "\n",
    "        # Create a dictionary with flattened keys\n",
    "        _df = pd.json_normalize(metric_dict)\n",
    "        \n",
    "\n",
    "        # Add additional information\n",
    "        _df[\"strategy\"] = strategy\n",
    "\n",
    "        # Look for exact label\n",
    "        _df[\"valid_label\"] = sum(results[\"exact_match\"])/len(results)\n",
    "\n",
    "        # Reorder columns\n",
    "        reordered_cols = _df.columns[-4:].append(_df.columns[:-4])\n",
    "        _df = _df[reordered_cols]\n",
    "\n",
    "        dfs.append(_df)\n",
    "\n",
    "    return pd.concat(dfs)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bea684de",
   "metadata": {},
   "source": [
    "# Llama2-MedTuned-13B"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "161f36d6",
   "metadata": {},
   "source": [
    "## RAG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "id": "c0639401",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.922680</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>0.224138</td>\n",
       "      <td>0.913793</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.00000</td>\n",
       "      <td>0.871795</td>\n",
       "      <td>0.931507</td>\n",
       "      <td>39.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.960000</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.855769</td>\n",
       "      <td>0.967949</td>\n",
       "      <td>0.889543</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.949602</td>\n",
       "      <td>0.913793</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.895873</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>0.224138</td>\n",
       "      <td>0.879310</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.571429</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.00000</td>\n",
       "      <td>0.820513</td>\n",
       "      <td>0.901408</td>\n",
       "      <td>39.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.960000</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.830769</td>\n",
       "      <td>0.955128</td>\n",
       "      <td>0.858209</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.942706</td>\n",
       "      <td>0.879310</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.763267</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>0.241379</td>\n",
       "      <td>0.724138</td>\n",
       "      <td>0.235294</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.380952</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.00000</td>\n",
       "      <td>0.641026</td>\n",
       "      <td>0.781250</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.5</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.4</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.857143</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.648109</td>\n",
       "      <td>0.743590</td>\n",
       "      <td>0.621320</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.891843</td>\n",
       "      <td>0.724138</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.846144</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>0.224138</td>\n",
       "      <td>0.827586</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.96875</td>\n",
       "      <td>0.794872</td>\n",
       "      <td>0.873239</td>\n",
       "      <td>39.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.5</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.960000</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.806290</td>\n",
       "      <td>0.782051</td>\n",
       "      <td>0.708310</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.917095</td>\n",
       "      <td>0.827586</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.922680                  58.0      zero_shot_vanilla     0.224138  0.913793     0.500000       1.0    0.666667        4.0      1.00000  0.871795    0.931507       39.0          1.0  1.000000         1.0        3.0     0.923077       1.0    0.960000       12.0             0.855769          0.967949            0.889543               58.0                0.949602             0.913793\n",
       "0               0.895873                  58.0  zero_shot_instruction     0.224138  0.879310     0.400000       1.0    0.571429        4.0      1.00000  0.820513    0.901408       39.0          1.0  1.000000         1.0        3.0     0.923077       1.0    0.960000       12.0             0.830769          0.955128            0.858209               58.0                0.942706             0.879310\n",
       "0               0.763267                  58.0       few_shot_vanilla     0.241379  0.724138     0.235294       1.0    0.380952        4.0      1.00000  0.641026    0.781250       39.0          0.5  0.333333         0.4        3.0     0.857143       1.0    0.923077       12.0             0.648109          0.743590            0.621320               58.0                0.891843             0.724138\n",
       "0               0.846144                  58.0   few_shot_instruction     0.224138  0.827586     0.333333       1.0    0.500000        4.0      0.96875  0.794872    0.873239       39.0          1.0  0.333333         0.5        3.0     0.923077       1.0    0.960000       12.0             0.806290          0.782051            0.708310               58.0                0.917095             0.827586"
      ]
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_columns', None)\n",
    "summarize_performance([\"ms-diag_Llama2-MedTuned-13b_4bit_all_test_zero_shot_vanilla_rag.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-13b_4bit_all_test_zero_shot_instruction_rag.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-13b_4bit_all_test_few_shot_vanilla_rag.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-13b_4bit_all_test_few_shot_instruction_rag.pt\",\n",
    "                       ], labels=\"label_encodings_Llama2-MedTuned-13b.pt\", load_line=False, load_outlines=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "88767f40",
   "metadata": {},
   "source": [
    "## Outlines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "id": "560f24fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.101649</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.120690</td>\n",
       "      <td>0.095238</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.173913</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.076923</td>\n",
       "      <td>0.133333</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.148810</td>\n",
       "      <td>0.269231</td>\n",
       "      <td>0.076812</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.342775</td>\n",
       "      <td>0.120690</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.602877</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.655172</td>\n",
       "      <td>0.200000</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.315789</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.833333</td>\n",
       "      <td>0.897436</td>\n",
       "      <td>0.864198</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.258333</td>\n",
       "      <td>0.411859</td>\n",
       "      <td>0.294997</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.574138</td>\n",
       "      <td>0.655172</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.380564</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.327586</td>\n",
       "      <td>0.111111</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.200000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.937500</td>\n",
       "      <td>0.384615</td>\n",
       "      <td>0.545455</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.262153</td>\n",
       "      <td>0.346154</td>\n",
       "      <td>0.186364</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.638051</td>\n",
       "      <td>0.327586</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.661919</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.706897</td>\n",
       "      <td>0.210526</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.347826</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.948718</td>\n",
       "      <td>0.948718</td>\n",
       "      <td>0.948718</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.289811</td>\n",
       "      <td>0.487179</td>\n",
       "      <td>0.324136</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.652450</td>\n",
       "      <td>0.706897</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.101649                  58.0      zero_shot_vanilla          1.0  0.120690     0.095238      1.00    0.173913        4.0     0.500000  0.076923    0.133333       39.0          0.0       0.0         0.0        3.0          0.0       0.0         0.0       12.0             0.148810          0.269231            0.076812               58.0                0.342775             0.120690\n",
       "0               0.602877                  58.0  zero_shot_instruction          1.0  0.655172     0.200000      0.75    0.315789        4.0     0.833333  0.897436    0.864198       39.0          0.0       0.0         0.0        3.0          0.0       0.0         0.0       12.0             0.258333          0.411859            0.294997               58.0                0.574138             0.655172\n",
       "0               0.380564                  58.0       few_shot_vanilla          1.0  0.327586     0.111111      1.00    0.200000        4.0     0.937500  0.384615    0.545455       39.0          0.0       0.0         0.0        3.0          0.0       0.0         0.0       12.0             0.262153          0.346154            0.186364               58.0                0.638051             0.327586\n",
       "0               0.661919                  58.0   few_shot_instruction          1.0  0.706897     0.210526      1.00    0.347826        4.0     0.948718  0.948718    0.948718       39.0          0.0       0.0         0.0        3.0          0.0       0.0         0.0       12.0             0.289811          0.487179            0.324136               58.0                0.652450             0.706897"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_columns', None)\n",
    "summarize_performance([\"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_zero_shot_vanilla.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_zero_shot_instruction.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_few_shot_vanilla.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_few_shot_instruction.pt\",\n",
    "                       ], labels=\"label_encodings_Llama2-MedTuned-7b.pt\", load_line=False, load_outlines=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "019c2552",
   "metadata": {},
   "source": [
    "## RAG + Outlines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "df948dde",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.263187</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.310345</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.5</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.025641</td>\n",
       "      <td>0.050000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.083333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.96</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.564103</td>\n",
       "      <td>0.631410</td>\n",
       "      <td>0.374295</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.884947</td>\n",
       "      <td>0.310345</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.251777</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.293103</td>\n",
       "      <td>0.088889</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.163265</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.025641</td>\n",
       "      <td>0.050000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.00</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.522222</td>\n",
       "      <td>0.506410</td>\n",
       "      <td>0.303316</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.885441</td>\n",
       "      <td>0.293103</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.867920</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.844828</td>\n",
       "      <td>0.800000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.888889</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.942857</td>\n",
       "      <td>0.846154</td>\n",
       "      <td>0.891892</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.00</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.685714</td>\n",
       "      <td>0.711538</td>\n",
       "      <td>0.695195</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.896059</td>\n",
       "      <td>0.844828</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.812289</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.793103</td>\n",
       "      <td>0.266667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.421053</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.967742</td>\n",
       "      <td>0.769231</td>\n",
       "      <td>0.857143</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.00</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.558602</td>\n",
       "      <td>0.692308</td>\n",
       "      <td>0.569549</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.876010</td>\n",
       "      <td>0.793103</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.263187                  58.0      zero_shot_vanilla          1.0  0.310345     0.250000       0.5    0.333333        4.0     1.000000  0.025641    0.050000       39.0     0.083333       1.0    0.153846        3.0     0.923077       1.0        0.96       12.0             0.564103          0.631410            0.374295               58.0                0.884947             0.310345\n",
       "0               0.251777                  58.0  zero_shot_instruction          1.0  0.293103     0.088889       1.0    0.163265        4.0     1.000000  0.025641    0.050000       39.0     0.000000       0.0    0.000000        3.0     1.000000       1.0        1.00       12.0             0.522222          0.506410            0.303316               58.0                0.885441             0.293103\n",
       "0               0.867920                  58.0       few_shot_vanilla          1.0  0.844828     0.800000       1.0    0.888889        4.0     0.942857  0.846154    0.891892       39.0     0.000000       0.0    0.000000        3.0     1.000000       1.0        1.00       12.0             0.685714          0.711538            0.695195               58.0                0.896059             0.844828\n",
       "0               0.812289                  58.0   few_shot_instruction          1.0  0.793103     0.266667       1.0    0.421053        4.0     0.967742  0.769231    0.857143       39.0     0.000000       0.0    0.000000        3.0     1.000000       1.0        1.00       12.0             0.558602          0.692308            0.569549               58.0                0.876010             0.793103"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_columns', None)\n",
    "summarize_performance([\"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_zero_shot_vanilla_rag.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_zero_shot_instruction_rag.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_few_shot_vanilla_rag.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-13b_4bit_all_test_few_shot_instruction_rag.pt\",\n",
    "                       ], labels=\"label_encodings_Llama2-MedTuned-13b.pt\", load_line=False, load_outlines=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c3ea678c",
   "metadata": {},
   "source": [
    "# Llama 7B"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c64df55f",
   "metadata": {},
   "source": [
    "## Base"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "2ccfdfbd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.358741</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>0.086207</td>\n",
       "      <td>0.310345</td>\n",
       "      <td>0.125000</td>\n",
       "      <td>0.50</td>\n",
       "      <td>0.200000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.888889</td>\n",
       "      <td>0.205128</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.086957</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.600000</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.545455</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.425211</td>\n",
       "      <td>0.467949</td>\n",
       "      <td>0.308159</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.734958</td>\n",
       "      <td>0.310345</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.539966</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>0.137931</td>\n",
       "      <td>0.465517</td>\n",
       "      <td>0.230769</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.352941</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.937500</td>\n",
       "      <td>0.384615</td>\n",
       "      <td>0.545455</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.055556</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.095238</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.727273</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.695652</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.487774</td>\n",
       "      <td>0.533654</td>\n",
       "      <td>0.422321</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.799647</td>\n",
       "      <td>0.465517</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.268652</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>0.086207</td>\n",
       "      <td>0.206897</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>0.266667</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.033333</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.060606</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.416667</td>\n",
       "      <td>0.416667</td>\n",
       "      <td>0.416667</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.362500</td>\n",
       "      <td>0.225962</td>\n",
       "      <td>0.185985</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.760345</td>\n",
       "      <td>0.206897</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.276609</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>0.103448</td>\n",
       "      <td>0.224138</td>\n",
       "      <td>0.090909</td>\n",
       "      <td>0.25</td>\n",
       "      <td>0.133333</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.461538</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.480000</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.304779</td>\n",
       "      <td>0.225962</td>\n",
       "      <td>0.215833</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.550036</td>\n",
       "      <td>0.224138</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.358741                  58.0      zero_shot_vanilla     0.086207  0.310345     0.125000      0.50    0.200000        4.0     0.888889  0.205128    0.333333       39.0     0.086957  0.666667    0.153846        3.0     0.600000  0.500000    0.545455       12.0             0.425211          0.467949            0.308159               58.0                0.734958             0.310345\n",
       "0               0.539966                  58.0  zero_shot_instruction     0.137931  0.465517     0.230769      0.75    0.352941        4.0     0.937500  0.384615    0.545455       39.0     0.055556  0.333333    0.095238        3.0     0.727273  0.666667    0.695652       12.0             0.487774          0.533654            0.422321               58.0                0.799647             0.465517\n",
       "0               0.268652                  58.0       few_shot_vanilla     0.086207  0.206897     0.000000      0.00    0.000000        4.0     1.000000  0.153846    0.266667       39.0     0.033333  0.333333    0.060606        3.0     0.416667  0.416667    0.416667       12.0             0.362500          0.225962            0.185985               58.0                0.760345             0.206897\n",
       "0               0.276609                  58.0   few_shot_instruction     0.103448  0.224138     0.090909      0.25    0.133333        4.0     0.666667  0.153846    0.250000       39.0     0.000000  0.000000    0.000000        3.0     0.461538  0.500000    0.480000       12.0             0.304779          0.225962            0.215833               58.0                0.550036             0.224138"
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_columns', None)\n",
    "summarize_performance([\"ms-diag_Llama2-MedTuned-7b_4bit_all_test_zero_shot_vanilla.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-7b_4bit_all_test_zero_shot_instruction.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-7b_4bit_all_test_few_shot_vanilla.pt\",\n",
    "                       \"ms-diag_Llama2-MedTuned-7b_4bit_all_test_few_shot_instruction.pt\",\n",
    "                       ], labels=\"label_encodings_Llama2-MedTuned-7b.pt\", load_line=False, load_outlines=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c00a6326",
   "metadata": {},
   "source": [
    "## Outlines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "48cc0238",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.169644</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.189655</td>\n",
       "      <td>0.088235</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.157895</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.076923</td>\n",
       "      <td>0.142857</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.238095</td>\n",
       "      <td>0.416667</td>\n",
       "      <td>0.303030</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.331583</td>\n",
       "      <td>0.310897</td>\n",
       "      <td>0.150946</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.727760</td>\n",
       "      <td>0.189655</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.275766</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.310345</td>\n",
       "      <td>0.222222</td>\n",
       "      <td>0.50</td>\n",
       "      <td>0.307692</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.153846</td>\n",
       "      <td>0.266667</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.232558</td>\n",
       "      <td>0.833333</td>\n",
       "      <td>0.363636</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.363695</td>\n",
       "      <td>0.371795</td>\n",
       "      <td>0.234499</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.735855</td>\n",
       "      <td>0.310345</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.071964</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.206897</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.210526</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.347826</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.052632</td>\n",
       "      <td>0.250000</td>\n",
       "      <td>0.086957</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.043557</td>\n",
       "      <td>0.206897</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.053393</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.137931</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.160000</td>\n",
       "      <td>0.666667</td>\n",
       "      <td>0.258065</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.040000</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>0.064516</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.033103</td>\n",
       "      <td>0.137931</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.169644                  58.0      zero_shot_vanilla          1.0  0.189655     0.088235      0.75    0.157895        4.0          1.0  0.076923    0.142857       39.0          0.0       0.0         0.0        3.0     0.238095  0.416667    0.303030       12.0             0.331583          0.310897            0.150946               58.0                0.727760             0.189655\n",
       "0               0.275766                  58.0  zero_shot_instruction          1.0  0.310345     0.222222      0.50    0.307692        4.0          1.0  0.153846    0.266667       39.0          0.0       0.0         0.0        3.0     0.232558  0.833333    0.363636       12.0             0.363695          0.371795            0.234499               58.0                0.735855             0.310345\n",
       "0               0.071964                  58.0       few_shot_vanilla          1.0  0.206897     0.000000      0.00    0.000000        4.0          0.0  0.000000    0.000000       39.0          0.0       0.0         0.0        3.0     0.210526  1.000000    0.347826       12.0             0.052632          0.250000            0.086957               58.0                0.043557             0.206897\n",
       "0               0.053393                  58.0   few_shot_instruction          1.0  0.137931     0.000000      0.00    0.000000        4.0          0.0  0.000000    0.000000       39.0          0.0       0.0         0.0        3.0     0.160000  0.666667    0.258065       12.0             0.040000          0.166667            0.064516               58.0                0.033103             0.137931"
      ]
     },
     "execution_count": 110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_columns', None)\n",
    "summarize_performance([\"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_zero_shot_vanilla.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_zero_shot_instruction.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_few_shot_vanilla.pt\",\n",
    "                       \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_few_shot_instruction.pt\",\n",
    "                       ], labels=\"label_encodings_Llama2-MedTuned-7b.pt\", load_line=False, load_outlines=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1ef6c7c0",
   "metadata": {},
   "source": [
    "## RAG + Outlines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "20749616",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>weighted avg.f1-score</th>\n",
       "      <th>weighted avg.support</th>\n",
       "      <th>strategy</th>\n",
       "      <th>valid_label</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>0.precision</th>\n",
       "      <th>0.recall</th>\n",
       "      <th>0.f1-score</th>\n",
       "      <th>0.support</th>\n",
       "      <th>1.precision</th>\n",
       "      <th>1.recall</th>\n",
       "      <th>1.f1-score</th>\n",
       "      <th>1.support</th>\n",
       "      <th>2.precision</th>\n",
       "      <th>2.recall</th>\n",
       "      <th>2.f1-score</th>\n",
       "      <th>2.support</th>\n",
       "      <th>3.precision</th>\n",
       "      <th>3.recall</th>\n",
       "      <th>3.f1-score</th>\n",
       "      <th>3.support</th>\n",
       "      <th>macro avg.precision</th>\n",
       "      <th>macro avg.recall</th>\n",
       "      <th>macro avg.f1-score</th>\n",
       "      <th>macro avg.support</th>\n",
       "      <th>weighted avg.precision</th>\n",
       "      <th>weighted avg.recall</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.852706</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.862069</td>\n",
       "      <td>0.444444</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.615385</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.871795</td>\n",
       "      <td>0.931507</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.800000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.888889</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.561111</td>\n",
       "      <td>0.717949</td>\n",
       "      <td>0.608945</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.868582</td>\n",
       "      <td>0.862069</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.706152</td>\n",
       "      <td>58.0</td>\n",
       "      <td>zero_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.706897</td>\n",
       "      <td>0.571429</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.727273</td>\n",
       "      <td>4.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.641026</td>\n",
       "      <td>0.781250</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.461538</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.631579</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.508242</td>\n",
       "      <td>0.660256</td>\n",
       "      <td>0.535025</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.807313</td>\n",
       "      <td>0.706897</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.116435</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_vanilla</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.258621</td>\n",
       "      <td>0.428571</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.545455</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.235294</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.380952</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.165966</td>\n",
       "      <td>0.437500</td>\n",
       "      <td>0.231602</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.078238</td>\n",
       "      <td>0.258621</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.202476</td>\n",
       "      <td>58.0</td>\n",
       "      <td>few_shot_instruction</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.275862</td>\n",
       "      <td>0.090909</td>\n",
       "      <td>1.00</td>\n",
       "      <td>0.166667</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>39.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.857143</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.923077</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.237013</td>\n",
       "      <td>0.500000</td>\n",
       "      <td>0.272436</td>\n",
       "      <td>58.0</td>\n",
       "      <td>0.183609</td>\n",
       "      <td>0.275862</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   weighted avg.f1-score  weighted avg.support               strategy  valid_label  accuracy  0.precision  0.recall  0.f1-score  0.support  1.precision  1.recall  1.f1-score  1.support  2.precision  2.recall  2.f1-score  2.support  3.precision  3.recall  3.f1-score  3.support  macro avg.precision  macro avg.recall  macro avg.f1-score  macro avg.support  weighted avg.precision  weighted avg.recall\n",
       "0               0.852706                  58.0      zero_shot_vanilla          1.0  0.862069     0.444444      1.00    0.615385        4.0          1.0  0.871795    0.931507       39.0          0.0       0.0         0.0        3.0     0.800000       1.0    0.888889       12.0             0.561111          0.717949            0.608945               58.0                0.868582             0.862069\n",
       "0               0.706152                  58.0  zero_shot_instruction          1.0  0.706897     0.571429      1.00    0.727273        4.0          1.0  0.641026    0.781250       39.0          0.0       0.0         0.0        3.0     0.461538       1.0    0.631579       12.0             0.508242          0.660256            0.535025               58.0                0.807313             0.706897\n",
       "0               0.116435                  58.0       few_shot_vanilla          1.0  0.258621     0.428571      0.75    0.545455        4.0          0.0  0.000000    0.000000       39.0          0.0       0.0         0.0        3.0     0.235294       1.0    0.380952       12.0             0.165966          0.437500            0.231602               58.0                0.078238             0.258621\n",
       "0               0.202476                  58.0   few_shot_instruction          1.0  0.275862     0.090909      1.00    0.166667        4.0          0.0  0.000000    0.000000       39.0          0.0       0.0         0.0        3.0     0.857143       1.0    0.923077       12.0             0.237013          0.500000            0.272436               58.0                0.183609             0.275862"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "summarize_performance([\"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_zero_shot_vanilla_rag.pt\",\n",
    "                          \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_zero_shot_instruction_rag.pt\",\n",
    "                          \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_few_shot_vanilla_rag.pt\",\n",
    "                          \"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_few_shot_instruction_rag.pt\",\n",
    "                          ], labels=\"label_encodings_Llama2-MedTuned-7b.pt\", load_line=False, load_outlines=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "4cab98fc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM, ED 12/2005), EDSS 1.0\\nklinisch fraglich aktiv, radiologisch aktiv, keine Progression (nach Lubin et al. 2013)\\nklinisch aktuell: Verschwommensehen bds angegeben, Schwankschwindel angegeben, sonst kein fokal-neurologisches Defizit\\nVerlauf:\\n12/2005 Hemisyndrom links, Dysarthrie, Dysästhesie\\n04/2014 Optikusneuritis rechts \\n10/2017 sensibles Hemisyndrom links\\n02/2020: Zunahme des bekannten Schwankschwindels, zusätzlich mono- und binokuläres Verschwommensehen bds, Visus 0.88 bds, sonst kein fokal-neurologisches Defizit DD leichter Schub im Rahmen der Läsion im Bereich der Radiatio optica DD Uthoff Phänomen i.R. eines viralen Infektes\\nDiagnostisch:\\n12/2005: Auswärtiges MRI vom 14.12.05: Multiple ZNS Läsionen, eine KM-anreichernd in der Medulla oblongata rechts.\\n12/2005 Liquor: Zellzahl und Protein normal, OKB positiv\\n12/2005 VEP auswärtig (Dr. Riederer): normal\\n05/2014 MRI Hirn: seit 03/2006 zeitliche Dissemination der nicht KM-anreichernden, demyelinisierenden Läsionen periventrikulär, subkortikal und infratentoriell mit/bei Neuritis N. optici rechts.\\n22.05.2015 cMRI: stationärer Befund\\n03.06.2016 cMRI: Eine neue supratentorielle Läsion in / an der Forceps major links. Zudem eine  fraglich neue punktförmige Läsion im cervicalen Myelon rechts.\\n03/2017 cMRI: 3 neue Läsionen, keine KM-Aufnahme\\n16.10.2017 cMRI: neue Läsionen, keine KM-Aufnahme\\n18.04.2018 cMRI: eine neue Gd+ Läsion\\n12.02.2020 cMRI: drei neue Gd+ Läsionen, eine neue Gd- Läsion (alle supratentoriell)\\nTherapie: \\n17.04.-21.04.2014 Methylprednisolon-Stosstherapie \\nBislang keine immunmodulatorische Therapie\\n15-19.10.2017: Solu-Medrol-Stoss-Therapie 1000mg/d\\nTherapie mit Tysabri (bei negativem JCV-Status) oder Ocrevus (bei positivem JCV-Status) geplant [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, EM 05/2018, ED 07/2018\\nINDENT EDSS 0.0\\nINDENT Aktuell: klinisch nicht aktiv, radiologisch nicht aktiv, keine Progression (nach Lublin 2013)\\nINDENT Verlauf: \\nINDENT 03.05.2018: Kribbelparästhesie im linken Fuss dorsalseitig und plantar, sowie intermittierend (< 24h) im linken Unterschenkel und im Verlauf linke palmare Handfläche\\nINDENT 29.06.2018: Kribbelparästhesien der rechten Wade, Krafteinschränkung der Beine, Gehstrecke auf 500-700 m eingeschränkt, Müdigkeit, Erschöpfbarkeit\\nINDENT 10.08.2018: vor ca. 2 Wochen  aufsteigende Progredienz der bekannten Kribbelparästhesien, Hypästhesie bis Höhe des Bauchnabels. Vorstellung in einer Klinik in Belgrad, dort Kortisonstoss, anschliessend Regredienz der Hypästhesien, allerdings neu augetretene Sehstörungen, sowie Verstärkung einer vorbekannten Urge-Inkontinenz.\\nINDENT 08/2018: Visus re. 0.9, reduzierte Sensibilität für alle Modalitäten sub TH5 Niveau, proximal betonte Paraparese, Ataxie OEX rechts und UEX rechtsbetont, ataktisches Gangbild\\nINDENT Labor: \\nINDENT Liquor 06/2018: Zellzahl 21/µl, OKBs im Liquor positiv, im Serum negativ; keine intrathekale IgM-/IgA-Synthese\\nINDENT Immunologisches Screening: Antinukleäre AK 1:320 (Anti-Chromatin/Histon/DFS70 negativ), ansonsten unauffällig \\nINDENT Anti-NMO und Anti-MOG negativ\\nINDENT Infektiologisches Schreening: negativ (HBV, HCV, HIV, Treponema pallidum, Borrelia burgdorferi)\\nINDENT Anti-JCV-AK am 27.06.2018: 3,13\\nINDENT Bildgebung:\\nINDENT cMRI 06/2020: Stationäre intrakranielle Läsionslast, keine neue oder KM-affine Läsion. \\nINDENT Therapie: \\nINDENT 07/2018: orale Cortisonstosstherapie mit Medrol 1000 mg/d \\nINDENT 07/2018: i. v. Cortisonstosstherapie 500mg/d (Klinik Belgrad, Wirkstoff unbekannt), 1000mg/d \\nINDENT 08/2018: i. v. Cortisonstosstherapie 2000mg/d \\nINDENT Seit 08/2018: Ocrelizumab[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nPrimär chronisch progrediente Multiple Sklerose, EM 2008, ED 2012, EDSS 4.0\\naktuell: klinisch: stabil, radiologisch: stabil, Progression: ja (nach Lublin et al. 2013)\\nINDENT Besserung der Kraft im linken Bein. Probleme beim Laufen, leichte Urge-Symptomatik und gelegentliche Einschlafprobleme. Klinisch spastisch-ataktisches Gangbild mit linksbetonter Spastik in den UE, beidseits gesteigerter PSR, Fallneigung im Rombergstehversuch nach hinten. Leichte Pallhypästhesie der UE (6/8).\\nINDENT Verlauf: \\nINDENT 1996 Sturz mit dem Rad\\nINDENT 2008 Lähmung des linken Beines nach körperl. Belastung, Parästhesien skelettal und im li. Oberschenkel\\nINDENT seit ca. 2013 neurogene Blasenstörung mit Dranginkontinenz\\nINDENT seit ca. 2014 progrediente Schwäche des rechten Beines\\nINDENT 02/2018: CD20-Antikörper-Therapie-assoziierte subakute Aggravation neurologischer Symptome unter Ocrelizumab\\nINDENT Diagnostik:\\nINDENT 2009 MRI Gehirn und WS: 3 periventrikuläre Läsionen, 1 Läsion auf Höhe C3/C4\\nINDENT 06/2012 Lumbalpunktion und Serum: TSH normal, ANA, CCP-Ak, Anti-Streptolysin, c-ANCA, p-ANCA, Glykoprotein 1, Hepatitis, HIV, Borrelien, T. pallidum negativ, unauffällige Elektrophorese, OKB im Liquor positiv (Fr. Dr. Strasser in Solothurn)\\nINDENT 12/2014 MRI Gehirn und WS: 1 neue Läsion im rechten frontalen Marklager, multiple T2-hyperintense Läsionen cervical ab C3, alle Läsionen ohne KM-Aufnahme \\nINDENT 03/2016 MRI Gehirn und Wirbelsäule: stationärer Befund zu 12/2014\\nINDENT 03/2017 MRI Gehirn: stationärer Befund\\nINDENT 03/2018 MRI Neuroachse: stationärer Befund\\nINDENT AK-Diagnostik: negativ für HBV, HCV, HIV\\nINDENT Therapie: \\nINDENT 03/2015 - 12/2017 Fampyra® 10 mg 1-0-1\\nINDENT Sativex® Spray \\nINDENT aktuell Ocrelizumab seit 02/2018, Erstgabe am 06.02.2018 300 mg, Zweiter Teil Erstgabe am 20.02.2018, 2. Zyklus am 17.08.2018, 3. Zyklus am 19.02.2019\\nINDENT 02/2018: CD20-Antikörper-Therapie-assoziierte subakute Aggravation neurologischer Symptome unter Ocrelizumab\\nINDENT Medrol 500 mg p.o. über 4 Tage vom 22.-25.02.2018\\nMigräne ohne Aura (ICHD-III beta 1.1)\\nanamnestisch: aktuelle Frequenz: alle 14 Tage für 24-48 Stunden, bilateral meist rechtsbetont und frontal  lokalisierte pulsierende Kopfschmerzen starker Intensität, begleitet von Nausea und Erbrechen, Photo- und Phonophobie[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM und ED 04/2007\\nINDENT Diagnostik\\nINDENT EDSS 05/2019: 2.0\\nINDENT MRI-Neuroachse 08/2018: Intrakraniell sowie spinal kein Nachweis von neuen oder KM-aufnehmenden Läsionen\\nINDENT MRI Schädel vom 08/2013: 1 neue gliotische Läsion im Übergang Mittelhirn zu oberem Kleinhirnschenkel der linken Seite\\nINDENT MRI Neuroachse vom 09/2012: Fraglich neue Läsion im Centrum semiovale post rechts, ansonsten stabiler Befund zerebral. Spinal fragliche Progredienz der Läsionen des thorakalen Myelons\\nINDENT Sensomotorisches Querschnittsyndrom, sensibel: sub-Th1, rechts-betont sowie distal-betont an allen Extremitäten, motorische Parese Kleinfinger rechts 04/2007\\nINDENT MRI Schädel vom 04/2007: ausgedehnt KM-aufnehmende Läsion C1-3, 2 kleine Läsionen obere u. untere BWS; multiple (> 20), nicht KM-aufnehmende periventrikuläre T2-Läsionen \\nINDENT Liquor 04/2007: Zellzahl 8/µlL Protein 0,48 g/L, IgG-Index 1.44, OKB positiv\\nINDENT Therapie:\\nINDENT aktuell: Teriflunomid (Aubagio) seit 05/2018\\nINDENT St.n. Plegridy 09/2015 - 05/2018\\nINDENT St.n. Tecfidera Therapie 05. - 06/2016\\nINDENT St.n. immunmodulatorische Therapie mit Betaferon 09/2007 -  03/2015\\nINDENT St.n. Solu-Medrol 3x 1 g 04/2007 [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose, schubförmiger Verlauf (EM 2006, ED 06.08.2014)\\nINDENT Verlauf:\\nINDENT 2006: Koordinationsstörung der rechten Körperhälfte\\nINDENT 05/2014 Parästhesien der Extemitäten li>re und Gesicht seit 05/2014\\nINDENT Diagnostik\\nINDENT laborchemisch 10/06: TSH, MAJ, TAK, Eiweisselektrophorese, C3- C4 Komplement, ACE normal\\nINDENT Serologie 10/06: Coxsackie-Virus- AL der Serotypen 1, 2, 6, Enteroviren AK; ANA : erhöht, HAV, HBV,HCV, CMV,HSV, und Luesserologie negativ, Vaskulitsserologie: unauffällig\\nINDENT Liquor vom 10/06: 6 mononukleäre Zellen/µl, Protein193 mg/l, OKB positiv\\nINDENT EEG  vom 10/06: unauffällig\\nINDENT Röntgen Thorax 10/06: unauffällig\\nINDENT zerebrales und spinales MRI 09/06: Herd mit Schrankenstörung zerebellär rechts unmittelbar neben dem 4. Ventrikel, MS vereinbare Läsion, winzige Signalhelligkeit in der Flair frontal rechts und subkortikal temporal links\\nINDENT MRI 31.07.2014 (Hirn und Myelon): 2 neue Läsionen, eine symptomgebend, Gd- (Vgl. zur VU 2006)\\nINDENT VEP 09/14: unauffällig\\nINDENT Therapie\\nINDENT bislang nihil[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nPrimär chronisch progrediente Multiple Sklerose (PPMS), EM 03/2017, ED 08/2017, EDSS 6.0\\nINDENT aktuell(10.04.19): \\nINDENT anamnestisch: seit 1 Woche bestehende Verschlechterung des Allgemeinzustands, Patient berichtet über Fatigue und allgemeine Schwäche. Ausserdem sei er verlangsamt beim Sprechen und bei körperlichen Aktivitäten, hierbei auch Schwindel. Leichte Visusverschlechterung li>re sei ihm auch aufgefallen. Auch das rechte Bein sei schwächer.\\nINDENT klinisch: psychomotorische Verlangsamung, leichte Dysarthrie, Visusverminderung, keine sonstigen neu hinzugetretenen neurologischen Ausfälle, vorbekannte Parese beinbetont rechts, rechtsbetonte Extremitätenataxie. \\nINDENT diagnostisch: \\nINDENT Labor: bland, kein Infektnachweis\\nINDENT Serologie: CMV und EBV negativ. \\nINDENT Bisheriger Verlauf: schleichend progredient, radiologisch: leicht progredient, Progression: ja (nach Lublin et al. 2013)\\nINDENT ab 03/2017 leichte Drangsymptomatik der Blase\\nINDENT ab 04/2017 Visusminderung links ohne Farbentsättigung oder Bulbusbewegungsschmerz\\nINDENT ab 05/2017 Kraftminderung des rechten Beines ab ca. 1 km Gehstrecke\\nINDENT ab 10/2017 weitere Kraftminderung des rechten Beines auf 500 m Gehstreck am Stück\\nINDENT ab 11/2017 leichte Visusminderung rechts \\nINDENT ab 03/2018 nach Ocrevus-Erstgabe elektrisierende Schmerzen in Unterarmen und Oberschenkeln bds.\\nINDENT ab 04/2018  beginnende Verschlechterung der Kraft im linken Arm\\nINDENT klinisch: spastisch-ataktische Gangstörung mit Stand- und Gang sowie leichter rechtbetonter Extremitätenataxie, leichte distal betonte Kraftminderung der Hände bds. rechtsbetont, mässige Fussheberparese rechts, Fernvisusminderung bds. von 0.5, aktuelle Gehstrecke 200m\\nINDENT diagnostisch:\\nINDENT Liquor 08/2017: OKBs pos. \\nINDENT Auto-AK-Screening und Infektionsserologien 01/2018: unauffällig für ANA, ANCA, RF, Kardiolipin-AK, negativ für HBV, HCV, HIV, Borrelien, Lues\\nINDENT VEPs 07/2017: bds. deutlich pathologische Latenzen\\nINDENT MRI Schädel 06.07.2017 (Radiologie Gersag, Emmenbrücke): multiple supra- und infratentorielle Läsionen, z.T. mit Aktivität\\nINDENT MRI HWS/BWS 13.07.2017 (Radiologie Gersag, Emmenbrücke): mehrere Demyelinisierungsherde im zervikalen und thorakalen Myelon, z.T. mit Aktivität\\nINDENT MRI Schädel/HWS 28.03.2018 (LUKS): eine kleine neue Läsion rechts temporal und leichte Grössenprogredienz einer pontinen Läsion rechts, keine KM-Aufnahme\\nINDENT MRI spinale Achse 06.04.2018 (LUKS): keine neuen oder aktiven Läsionen\\nINDENT JCV-AK-Test 01/2018: positiv (Titer 3.1)\\nINDENT MR Myelon 08/2018: keine neuen oder aktiven Läsionen\\nINDENT therapeutisch:\\nINDENT 08/2017 14 Tage Medrol\\nINDENT 02/2018 Solu-medrol-Stosstherapie 1g über 5 Tage\\nINDENT 08/2017- 03/2018 Plegridy\\nINDENT seit 03/2018 Ocrevus (bislang eine Gabe erfolgt), darunter  elektrisierende Schmerzen in den Unterarmen und Oberschenkeln bds., unter Lyrica 100 mg/d regredient \\nINDENT autologe Stammzelltransplantation\\nINDENT Mobilisationschemotherapie ab 07.09.2018\\nINDENT Cyclosphamid 2 g/m2 (absolut 4000 mg) Tag 1-2\\nINDENT Mesna 1600 mg Bolus und 2400 mg kontinuierliche Infusion für 24h Tag 1-2\\nINDENT G-CSF gemäss separatem Plan ab 10.09.2018\\nINDENT Hochdosistherapie mit BEAM ab 29.09.2018 \\nINDENT Carmustin 300 mg/m2 abs. 627 mg d1\\nINDENT Etoposid200 mg/m2 abs. 418 mg d1-4\\nINDENT Cytarabin 200 mg/m2 abs. 418 mg d1-4\\nINDENT Melphalan 140 m/m2 abs. 293 mg d1\\nINDENT Autologe Stammzellretransfusion von 4.29 Mio CD34+ Zellen/kgKG am 05.10.2018\\nINDENT Rabbit ATG (Thymoglobuline®) 3.75 mg/kg abs. 325 mg d+1 und d+2 [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM und ED 05/2013), EDSS 2.0\\nINDENT Klinisch: Nicht aktiv; radiologisch: Nicht aktiv; Progression: Nein (Lublin, 2013)\\nINDENT Aktuell: residuell dezente Hypästhesie der rechten Körperhälfte, Hypakusis rechts\\nINDENT Verlauf:\\nINDENT 05/2013: Erstmanifestation mit Optikusneuritis rechts\\nINDENT 05/2013: Rezidivierende kurzzeitige Episoden mit Schwindel \\nINDENT 25.06.2013 Schub: Hemihypästhesie rechts (distal betont), nach Cortison vollständig regredient\\nINDENT 07.08.2013: fragl. Schub: Erneute Hemihypästhesie re distalbetont (ähnliche Symptomatik wie im Juni), Cortisontherapie \\nINDENT 09/2014: zunehmendes Taubheitsgefühl im rechten Arm, nach Cortisontherapie regredient\\nINDENT 12/2014:  weiterhin Hypästhesie komplette rechte Körperhälfte, keine Kraftminderungen\\nINDENT 07/2015: Hemihypästhesie re distalbetont (ähnliche Symptomatik wie im August 2013), neurogene Blasenstörung, Cortisontherapie \\nINDENT diagnostisch:\\nINDENT Labor\\nINDENT 05/2013 Liquor: 0 Zellen/µl, Glukose, Laktat und Protein normal, OKBs im Liquor positiv (im Serum negativ)\\nINDENT 06/2013 - 07/2014 JCV-Stratify: Positiv, Index >2,7, zuletzt Index 3.468\\nINDENT 08/2014 Liquor : JCV neg., 0 Zellen/µl, Glukose, Laktat und Protein normal, OKB neg.\\nINDENT FACS Immunphänotypisierung: 01/2017 Depletion aller CD20+/CD19+ Zellen; 05/2017: eine kleine CD19+CD20+ B-Zellpopulation nachweisbar, die ca. 0.3% der untersuchten Lymphozyten ausmacht\\nINDENT Bildgebung\\nINDENT 07/2013 - 05/2018 cMRI: stationärer Befund, keine Hinweise für PML, keine KM-Aufnahme\\nINDENT 07/2013 - 03/2017 MRI spinal: stationärer Befund, 2 Läsionen Höhe T8-T9 und T11, ohne floride Komponente.\\nINDENT cMRI vom 27.10.2018: Unveränderte Darstellung der supra- und infratentoriellen Läsionen. Keine neuen Läsionen. Keine pathologische Schrankenstörung.\\nINDENT therapeutisch:\\nINDENT 07/2013 - 07/2014 Tysabri 300mg zunächst alle 4 Wochen, 03/2014 - 07/2014 alle 6 Wochen (off-label) \\nINDENT 08/2014- 12/2016: Dimethylfumarat \\nINDENT seit 12/2016: Therapie mit Rituximab (375mg/m2 KOF alle 6 Monate)\\nINDENT 1.Gabe am 16.12.2016 (520 mg i.v.)\\nINDENT 2. Gabe 13.06.2017 (525mg)\\nINDENT 3. Gabe 11.12.2017 (520mg)\\nINDENT 4. Gabe am 25.06.2018 (520 mg) CD20-B-Lymphozyten 1%\\nINDENT 5. Gabe (525mg) [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSt. n. Bimaxilläre Retrognathie mit/bei:\\nINDENT St. n. Le Fort I Osteotomie und sagittale Spaltung Unterkiefer beidseits am 08.02.2011[/INST]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nAkne papulopustulosa \\nINDENT Auftreten nach Absetzten der hormonellen Verhütung in der Schwangerschaft \\nTherapie: \\nINDENT St. n. Epiduo Gel \\nINDENT geplant anti-androgne Pille  (sinnvoll bei Alter?)[/INST]\\nDiagnosis:\\nnot enough info',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige multiple Sklerose (ED Januar 2013)[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n39-jährige Patientin mit sekundärer Sterilität seit 06/2010\\nINDENT aktuell in der Zyklusanamnese bestehende Menometrorrhagien \\nINDENT analgetikapflichtige Dysmenorrhoe\\nINDENT Uterus myomatosus\\nINDENT MRI Abdomen vom 11.10.2019: V. a. eingeblutete Ovarialzysten beidseits DD Endometriome. Hämatosalpinx links. Myom Seitenwand rechts FIGO 2 von 4.8 x 3.6 x 4.3 cm. Niche bei St. n. Sectio mit allenfalls noch minim angrenzendem myometralen Saum\\nINDENT Myomektomie Vorderwand im 11/2019 (Pfannenstiellaparotomie), postoperativ Revision bei epifaszialem Hämatom\\nINDENT Endometriose rASRM Grad IV ED 11/2019, Beginn Therapie mit Visanne\\nINDENT St.n. erfolgloser Embryotransfer nach Eizellspende in Indien am 09.07.2018\\nINDENT St.n. mehrfachem Abbruch wegen polyfollikulärer Reaktion unter Clomid und Gonal F seit 09/2014\\nINDENT Malcompliance mit ungeschütztem GV und polifollikulärer Reaktion \\nINDENT unkontrollierter Therapieversuch mit Gonadotropinen zu Hause 5/2017\\nINDENT St.n. Gonadotropin-Stimulation und getimtem GV (auf Wunsch) ohne SS 10/2014\\nINDENT St.n. Sectio caesarea 2000 (Schwangerschaft spontan eingetreten, anderer Partner)\\nINDENT Valvuläre Kardiopathie\\nINDENT Kombiniertes nicht verkalktes postrheumatisches Mitralvitium\\nINDENT St. n. Mitralvalvuloplastie 8/99\\nINDENT ED im Rahmen der ersten Schwangerschaft 1999 bei Anstrengungsdyspnoe ab der 11. SSW\\nINDENT Kardiologie,17.03.2016: klinisch und echokardiographisch stabilem Verlauf, mittelschwere Mitralinsuffizienz und leichte residuelle Mitralstenose ohne pulmonale Drucksteigerung\\nINDENT bei Eintritt einer Schwangerschaft engmaschige Kontrollen in der kardiolog. Sprechstunde sowie niedermolekulares Heparin empfohlen \\nINDENT Geburtshilfliches Konsil mit Empfehlung Mehrlingsschwangerschaften zu vermeiden, Kontrollen am Zentrum empfohlen \\nINDENT letzte kardiologische Kontrolle18.03.2015\\nPartner:\\nINDENT Männliche Subfertilität (Asthenoteratozoospermie 10/13, Teratozoospermie 12/13). \\nINDENT Urolog. Abklärung im USZ erfolgt: PSA erhöht 02/2014, Verlaufskontrolle normwertig 05/2014, jährliche Kontrollen bei HA empfohlen\\nINDENT Probatorische Aufbereitung IUI und IVF geeignet 03/14[/INST]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nV.a. primär progrediente Multiple Sklerose, EM 08/2016, ED 10/2018, EDSS 4.5\\nINDENT aktuell: klinisch: nicht aktiv, radiologisch: unklar, Progression: ja (nach Lublin 2013)\\nINDENT Verlauf: \\nINDENT 08/2016: Schwäche und Trauma Fuss links mit Fuss, Trauma mit Bimalleolarluxationsfraktur OSG links, postoperativ progrediente Zunahme der Schwäche des linken Fusses\\nINDENT 02/2019: Zunahme der Schwäche und Steifigkeit des linken Beines, seitdem weiter progredienter Verlauf\\nINDENT 10/2020: leichte Schwäche und Steifigkeitsgefühl des rechten Oberarmes\\nINDENT klinisch:\\nINDENT diagnostisch:\\nlaborchemisch:\\nINDENT LP vom 27.11.2018 (Spital Bülach): 1 Zelle/ul, Protein normal, keine Schrankenstörung, OKB positiv\\nBildgebend:\\nINDENT MR BWS-LWS 10/2018 (Spital Bülach): Mehrere T2w hyperintense Signalalteraltionen im posterioren und lateralen Funiculus rechts und singulär im lateralen Funiculus links des thorakalen Myelons, es ergibt sich der Verdacht auf demyelinisierende Plaques. Keine Schrankenstörung als Zeichen einer akuten Entzündungsaktivität. isolierte Diskushernie BWK 2/BWK 3 ohne Nervenwurzelkompression. \\nINDENT MR Schädel und HWS 11/2018 (Spital Bülach): Gemäss der McDonald Kriterien (Revision 2017): Bsp. Klinische Attacke und räumliche Dissemination erhärtet der intrazerebrale Befund den Verdacht auf eine MS bei demyelinisierenden Plaques in mindestens 6 MS-typischen Lokalisationen (periventrikulär und juxtakortikal. Weiterer Plaque im zervikalen Myelon auf Höhe von HWK 2 links. Kein Nachweis von aktiven Läsionen. \\nINDENT MR Schädel 04/2019: stationär, keine aktive Läsionen.\\nINDENT MR HWS/BWS/LWS 04/2019: Bekannte Demyelinisierungsherde im zervikalen und thorakalen Myelon. Kein Nachweis neu aufgetretener Plaques. Nach Kontrastmittelapplikation zeigt der Herd auf Höhe BWK 6 eine flaue Anreicherung als Hinweis auf eine gewisse Aktivität.\\nINDENT MRI Schädel 01/2021: Neue, a.e. demyelinisierende Läsion im Gyrus frontalis medius links mit subcorticalen Beteiligung entlang der U-Fasern. Keine sichere Kontrastmittelaufnahme ebenda. Ansonsten konstante Läsionslast supratentoriell und infratentoriell und im zervikalen Myelon, keine Aktivitätszeichen.\\nINDENT MRI HWS 01/2021: Neue kleine demyelinisierende Läsion auf Höhe HWK 6 im Funiculus lateralis rechts sowie auf Höhe HWK 4 im Funiculus lateralis links. Bekannte MS-Läsionen auf Höhe HWK 2/3 etwas regredient. Keine Zeichen einer entzündlichen Aktivität. Gering progredienter medianer Bandscheibenprolaps auf Höhe BWK 2 / 3 mit geringem Umschlagen nach cranial.\\nINDENT therapeutisch:\\nINDENT Methylprednisolon 100mg für 3 Tage am 25.10.2018\\nINDENT Lioresal 10mg bis 0.5-0.5-2 (Besserung Gangbild, aufgrund starker Müdigkeit gestoppt)\\nINDENT seit 06/2019 Tecfidera 240mg 1-0-1\\nStatus nach Bimalleolarluxationsfraktur OSG links, 08/2016\\nINDENT Status nach Platten- und Schraubenosteosynthese 11.08.2016[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nVd.a. Lokal-Injektions-Reaktion auf Interferon beta-Injektion\\nINDENT DD kontaktallergische Reaktion auf Rebif[/INST]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n1. EM 1992, ED 1',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig remittierende Multiple Sklerose (EM 09/14), EDSS 0.0\\nINDENT Klinik\\nINDENT aktuell:  komplette Remission der Opticus neuritis rechts und links, klinisch keine Beschwerden\\nINDENT Verlauf: \\nINDENT 28.09.14: Neuritis nervi optici rechts - Remittiert bis ca. 11/14\\nINDENT vor 09/14 und ca. 10-11/14: zwei Episoden mit Taubheitsgefühl rechtskorporal\\nINDENT ca. 12/14: anamnestisch Neuritis nervi optici links - komplett remittiert\\nINDENT fragl. neurogene Blasenstörung: erschwertes Wasserlassen\\nINDENT Diagnostik\\nINDENT Serologien für HIV, Borrelien, Treponema pallidum negativ\\nINDENT Immunologisches Screen negativ\\nINDENT Liquor 27.01.15: positive oligoklonale Banden\\nINDENT cMRI 02.10.14: multiple supra- und infratentorielle demyelinisierende Läsionen in MS-typischen Lokalisationen, Gd-, geringes KM-Enhancement Nervus opticus rechts\\nINDENT cMRI 25.11.14: Neue KM-aufnehmende Läsionen im Centrum semiovale rechts, periventrikulär auf Höhe der Cella media links, occipital links sowie cerebellär rechts.\\nINDENT MRI spinal 03.12.14: Multiple spinale demyelinisierende Läsionen in C1-C8, Th9/10, Th10/11 ohne KM-Aufnahme\\nINDENT Liquor 01/15: positive OKBs\\nINDENT VEP 01/15: kein Latenzunterschied\\nINDENT Therapie \\nINDENT 03.10.14 - 08.10.14: Medrol 500mg/d\\nINDENT geplant: März Start Gilenya [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nEntzündliche ZNS-Erkrankung, EM 03/2016\\nINDENT anamnestisch: vor ca. 4 Wochen Symptombeginn mit Schwankschwindel, verstärkt beim Blick nach rechts und oben, Gangunsicherheit, Entwicklung von Lichtempfindlichkeit, aktuell Schwindelsymptomatik vollständig regredient\\nINDENT klinisch: fokal-neurologisch unauffällig\\nINDENT diagnostisch: \\nINDENT MRI Schädel vom 09.03.2016 (extern): keilförmige T2-Hyperintensität in der Fossa rhomboidea, zudem mehrere juxtakortikale und paraventrikuläre Läsionen \\nINDENT MRI Schädel und WS vom 20.04.16: vorbekannte demyelinisierende Läsionen infra- und supratentoriell; Im thorakalen Myelon fraglich fokale T2-Signalalterationen auf Höhe BWK 5 und BWK11.\\nINDENT LP vom 21.04.16: Zellzahl 7/ul, intrathekale IgG-Synthese, normwertiges Protein\\nINDENT OCT-Untersuchung vom 21.04.16: Abnahme der Nervenfaserschichtdicke temporal rechts[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 05/2015, ED 07/2015)\\nEDSS: 2.0 (Pyz: 1.0; Sens: 2.0; Cerebral/Fatigue: 2.0)\\nKlinisch:\\nINDENT Aktuell: Parästhesien an Kopf v.a. occipital, Nacken und den Beinen li > re  \\nINDENT Residuell: intermittierende Visusminderung links, Schwäche und Gangunsicherheit, schwere Fatigue mit Konzentrationsstörungen und Gedächtnisschwierigkeiten \\nINDENT Verlauf: \\nINDENT Mai 2015: Episode mit Schwindel (und Kopfschmerzen) für 4 Tage \\nINDENT 11/2015: Zunahme der Gangunsicherheit und ein Schwächegefühl an beiden Beinen\\nINDENT 07/2016: Opticusneuritis links\\nDiagnostisch: \\nINDENT cMRI 06/2015: vereinzelte T2-hyperintense Läsionen perivenrtrikulär, balkennah\\nINDENT cMRI 12/2015:  neue demyelinisierende Läsionen des Zentrum semiovale und periventrikulären Marklagers \\nINDENT MRI spinal 07/2015: kontrastmittelaufnehmende, aktive Läsionen des zervikalen Myelons auf Höhe HWK 5/6 linksseitig; nicht kontrastmittelaufnehmende Läsionen des thorakalen Myelons auf Höhe BWK 9 sowie auf Höhe BWK12\\nINDENT Liquor 07/2015: ZZ 10/µl, IgG Index erhöht, OKB positiv\\nINDENT immunologisches Screening und Erregerdiagnostik: negativ\\nINDENT VEP 07/2015: unauffällig\\nTherapeutisch:\\nseit 20.02.2017: Gilenya 0.5 mg täglich[/INST]\\nDiagnosis:\\nschubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n Schubförmige Multiple Sklerose (EM 04/2010, ED 06/2010), EDSS: 2.0\\nINDENT aktuell: stabiler Verlauf\\nINDENT klinisch residuell: Angabe von Doppelbildern beim Blick nach links, intermittierend auftretende Kribbelparästhesien der Hände und Füsse, Hypästhesie sub Th10 \\nINDENT Verlauf:\\nINDENT - 05/2010 Retrobulbärneuritis re > li\\nINDENT - 06/2010 Kribbelparästhesien und Hypästhesie beider Unterschenkel und Unterarme, Pallhypästhesie der unteren Extremitäten\\nINDENT -12/2010 Hypästhesie des Bauches und Blasenstörung\\nINDENT diagnostisch:\\nINDENT - 06/2010 Liquor: OKB positiv, Zellzahl 4/ul\\nINDENT - 06/2010 MRI cerebral und spinal : bilaterale, rechtsbetonte akute     Retrobulbärneuritis sowie drei entzündliche Läsionen des Parenchyms, eine akut entzündliche Läsion re frontal. 3 postenzündliche Läsionen, davon eine mit lokaler Atrophie\\nINDENT - 07/2010 VEP: bds pathologisch (re>li)\\nINDENT - 12/2010 MRI cerebral und spinal: Neue kleine Läsion im Rückenmark auf Höhe Th10\\nINDENT - 01/2011 NPSY: mittelschwere Minderleistungen beim Abruf und z.T. Wiedererkennen aus dem episodischen Gedächtnis. Leichte Fatigue-Symptomatik.\\nINDENT - 05/2011 MRI cerebral und spinal: Im Vergleich mit dem cranialen MRI von vor 11   Monaten gleichbleibendes Ausmass der wenigen entzündlichen      Demyelinisierungen des supratentoriellen Marklagers. Neu aufgetretene   entzündliche Läsionen beidseits in Projektion auf den Nucleus cuneatus und gracilis bis in das Zervikalmark reichend. Kein Nachweis einer akuten Entzündung. Kein Hinweis auf eine PML.\\nINDENT - JCV-Test vom 11.07.2011: positiv; Patient wurde am 8.08.2011aufgeklärt; Einverständnis des Patienten für Fortsetzung der Tysabri-Therapie gegeben.\\nINDENT - 12/2011 NPSY: Nahezu identisches kognitives Leistungsprofil im Vergleich zur Voruntersuchung\\nINDENT therapeutisch:\\nINDENT - 08/2010-10/2010 Avonex 1 x wöchentlich i.m. \\nINDENT - seit 25.10.2010 Tysabri 300 mg i.v. alle 4 Wochen    \\nINDENT - Ocrevus 300mg seit 08/2018, letztmalig (3. Zyklus) am 10.09.19[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (RRMS), EM 05/2003, ED 08/2003, EDSS 2.0 \\naktuell am 30.10.2019: AZ Minderung mit Übelkeit und wiederholtem Erbrechen\\nINDENT ätiologisch: a.e. i. R. einer virale Gastrointeritis und HWI\\nINDENT klinisch: Leicht psychomotorisch verlangsamt. Proximale Schwäche der Beine (Hüftflexion M4+/4+, Hüftextension M4+/4+)\\nINDENT diagnostisch: \\nINDENT Labor: CRP 42mg/l, Lc 8.96G/l, Influenza-A/B, RSV negativ\\nINDENT U-Status: Nitrit pos. HWI\\nINDENT Rx-Thorax: kein Infiltrat\\nINDENT therapeutisch: Beginn mit Rocepin 2mg/24h am 30.10.19 bis 02.11.19, dann Augmentin 3x625mg bis 05.11.19\\nVerlauf: \\nINDENT 16.10.2019: klinisch nicht aktiv, radiologisch unklar, keine Progression (nach Lublin et al. 2013)\\nINDENT 05/2003 Schub mit Hemisyndrom links\\nINDENT 08/2003 Schub mit Abduzensparese rechts\\nINDENT 09/2008 Schub mit Sensibilitätsstörung rechte Hand und linkes Bein \\nINDENT 06/2014 Schub mit Hypästhesie der rechten Körperseite\\nINDENT 07/2014 Schub sensibles Querschnittssyndrom mit Kribbelparästhesien und Hypästhesie ab sub Th11\\nINDENT 21.04.2017 sensibles Querschnittssyndrom sub Th12, Vollständige Besserung durch Cortison\\nINDENT 12/2017 Schub mit Hypästhesie rechte Hand und rechter Fuss mit unvollständiger Rückbildung nach Cortison\\ndiagnostisch:\\nLabor\\nINDENT Liquor (USZ): oligoklonale Banden positiv, IgG-Index erhöht (1.86)\\nINDENT JCV-Serologie: (getestet halbjährlich) 10/2013 - 07/2016 negativ (Index 0.10), einmalig postitv 01/2018 (0.38) im Anschluss immer negativ\\nBildgebung\\nINDENT cMRI 06/2015, 11/2015, 06/2016: Keine neuen Läsionen. keine KM-Aufnahme, kein Hinweis auf PML \\nINDENT 06/2016 MRI spinal (im Vergleich zu 07/2015): Stationäre Läsionen zervikal und thorakal. Nach KM-Gabe fragliche Signalanhebung der Läsionen auf Höhe BWK 3/4 und auf Höhe BWK8, DD Artefakte.\\nINDENT cMRI 31.10.2019: unveränderte Läsionslast.\\ntherapeutisch:\\nINDENT 12/2003 - 12/2013  Rebif s.c. 3 x 44µg pro Woche  \\nINDENT 01/2014 - 07/2014 Dimethylfumarat 2 x 240mg pro Tag, Umstellung wegen Entzündungsaktivität\\nINDENT 06/2014, 07/2014, 08/2014 Cortisonstosstherapie\\nINDENT seit 08/2014: Tysabri 300 mg iv. alle 4 Wochen, seit 10/2016 pausiert wegen Schwangerschaft\\nINDENT 05/2017 2x mit 10 Tagen Abstand: Solu-Medrol 1g i.v. über 5 Tage\\nINDENT ab 08/2017 10g IVIG Privigen i.v., alle 4 Wochen (insgesamt 5 Gaben)\\nINDENT Wiederbeginn mit Tysabri ab Jan 2018 in der Neuropraxis Bellevue, insgesamt 20 Gaben JCV im 01/2018 einmalig 0.38 sonst immer negativ[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (ES und ED 4/03, aktueller EDSS 0.0)\\nAktuell: keine neurologischen Defizite\\nDiagnostisch\\nINDENT -  Schädel-MRI (4/03): Mehrere T2-hyperintense Läsionen (teils KM-Enhancement)\\nINDENT -  Schädel-MRI (10/03): Neuer Herd Rand Corpus callosum li\\nINDENT -  Liquor (4/03): ZZ 15/µl, OKB+\\nKlinisch\\nINDENT -  1. Schub (4/03): Parese und Sensibilitätsstörung linke Hand (Remission)\\nINDENT -  2. Schub (10/03): inkomplettes sensibles Querschnittssyndrom Höhe Th8 (Remission)\\nINDENT -  3. Schub (2/06): inkompl. sensibles Querschnittssyndrom ab ca L2, sowie\\n   diskrete Schwäche linker Arm und fraglich auch rechtes Bein (Remission)\\nINDENT -  4. Schub 06/13: Retrobulbärneuritis links \\nTherapeutisch\\nINDENT - Betaferon 8 Mio. IE jeden 2. Tag seit 1/04-2008, danach selbstständig sistiert\\nINDENT - Solumedrol IV 2/06\\nINDENT - Solumedrol 1g i.v. 21.-26.6.  \\nINDENT - Gilenya seit 26.8.13 - ongoing[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nV.a. entzündliche ZNS-Erkrankung, EM 23.11.2015\\nINDENT DD CIS, ADEM\\nINDENT Anamnese: Kribbeln der linken Körperhälfte seit ca. 23.11.2015 langsam zunehmend; Mutter mit MS\\nINDENT Klinik: sensomotorisches beinbetontes Hemisyndrom links, Koordinationsstörung Hand links, Kraftgrad Bein links M4, im Verlauf zunehmend mit Parese im Arm links distal bis M4 und im Bein links M3, im weiteren Verlauf deutliche Regredienz, bei Austritt residuell diskrete Kraftminderung und Feinmotorikstörung in der linken Hand sowie leichte Hypästhesie und Dysästhesien im Arm links\\nINDENT cMRI: FLAIR/T2 hyperintense Läsionen infratentoriell, juxtacortical und periventrikulär, teils T1 hypointens, die grösste Läsion am Hinterhorn des Ncl. caudatus, bis knapp an die Inselrinde reichend rechts reichert randständig punktuell etwas KM an\\nINDENT Liquoranalyse: 1 Zelle/ul, Protein, Glucose und Lactat normal, OKB im Liquor positiv, grenzwertiger IgG-Index\\nINDENT Blut: Borrelien- und Lues-Serologie negativ, Rheumalabor negativ, Virologie ohne Hinweis auf aktive Infektion\\nINDENT Therapie: Cortisonstoss mit 500 mg Methylprednisolon/d p.o. ab 29.11.2015 über 5 Tage, bei klinischer Progredienz ab 04.12.2015 1000 mg Methylprednisolon/d i.v. über 5 Tage, darunter Regredienz[/INST]\\nDiagnosis:\\nschubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, EM 09/2020, ED 12/2020, EDSS 3.0 \\nINDENT klinisch: aktiv, radiologisch: aktiv, Progression: keine (nach Lublin 2013)\\nINDENT anamnestisch: Ende September 2020 aufgewacht mit Kribbeln in beiden Beinen und gestörter Erektion für 2-3 Tage, nach 2-3 Tage Kribbeln aufsteigend in Rumpf und Fingerspitzen, aktuell in den Beinen nicht mehr vorhanden. Aktuell seit zwei Wochen leiche Schwäche, Taubheit und Koordinationsstörung der linken Hand.\\nINDENT klinisch: vermindertes Berührungsempfinden in den Fingerspitzen, Pallhypästhesie 6/8 bimalleolär/bipatellär, Schmerzempfinden allseits seitengleich intakt, gering verplumpte Fingerbewegungen links, Linksseitig erhöhter Muskeltonus im Bein, Babinski fraglich positiv bds., vermehrte Fusskloni beidseits links mehr als rechts, Romberg unsicher. Ansonsten kein fokal-neurologisches Defizit.\\nINDENT diagnostisch:\\nINDENT Labor (extern) 10/2020: Calcium/Magnesium normwertig, Vitamin D/Vitamin B12 normwertig, Harnsäure und Cholesterin leicht erhöht\\nINDENT Lumbalpunktion 11/2020: Zellzahl 21/µl, vorw. mononuklär, Protein normal, OKB pos, MRZ tripel pos.\\nINDENT Infektscreening 11/2020: HBV geimpft, HCV neg., HIV neg., Borrelien AK neg., Lues EIA pos., Lues IgM pos. (Frühinfekt oder unsgezifisch, s. Dg2)\\nINDENT Immunologie-/Vaskulitis-Screening: ANA 1:320 (a.e. unspezifisch), Anti-dsDNA, Anti-Ro/La, Anti-B2-GP-AK, ANCA, Anti-MPO negativ, Anti-NMO, Anti-MOG negativ, Folsäure erniedrigt, Vit. D-Mangel\\nINDENT Bildgebung:\\nINDENT MRI Gehirn 11/2020: Multiple Läsionen infra- und supratentoriell in einem entzündlichen Verteilungsmuster, teilweise mit Kontrastmittelaufnahme, sehr suggestiv für das Vorliegen einer chronisch entzündlichen demyelinisierenden ZNS-Erkrankung. Die bildgebenden McDonald Kriterien für Dissemination in Zeit und Ort sind erfüllt. Vd. a. akuten entzündlichen Schub.\\nINDENT MRI WS 11/2020: Mehrere Läsionen des zervikalen und thorkalen Myelons, sehr suggestiv für chronisch enzündliche demyelinisierende ZNS-Erkrankung. Kontrastmittelaufnahme im Bereich des zervikalen Myelons, Vd. a. akuten entzündlichen Schub.\\nINDENT therapeutisch:\\nINDENT Cortisolstosstherapie 11/2020 (1 g Solumedrol i.v. für 5 d)\\nINDENT Cortisolausschleichschema p.o. Methylprednisolon 100 mg ausschleichend (Reduktion 25 mg über 2d)\\nINDENT Eskalationstherapie bei fortbestehenden/zunehmenden Symptomen Methylprednisolon 500 mg/d über 5 Tage 04.12. - 08.12.2020[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose\\nES 03, ED 10/2008 (gesichert nach McDonald Kriterien)\\nklinisch: \\naktuell: residuelle Feinmotorikstörung und Hypästhesie der linken Hand, \\nleichte neurogene Blasenstörung (Drangsymptomatik, kein Restharn), EDSS 2.0\\nVerlauf:\\nINDENT - 2003 passagere Visusstörung rechtes Auge \\nINDENT - 2007 passagere Temperaturmissempfindung der Füsse\\nINDENT - 09-10/2008 sensibles Hemisyndrom und Feinkoordinationsstörung links\\ndiagnostisch:\\nINDENT - 09/2010 neuropsychologische Untersuchung: meist normgerechte testdiagnostische   Befunde. Kein Hinweis auf eine Fatigue- oder Depressionsymptomatik.\\nINDENT - 09/2010 MRI Gehirn: Zahl- und grössenmässig tendentielle, wenngleich relativ geringe,   Progredienz der Enc.diss. Läsionen supra- und infratentoriell. Kein Anhaltspunkt für   aktuelle Aktivität einer Läsion.\\n - 10/2008 MRI cerebral und spinal: multiple cerebrale T2-hyperintense Läsionen,\\n  davon eine KM aufnehmende Läsion in der Corona radiata paraventrikulär  \\n    rechts; multiple intramedulläre Läsionen, zwei mit Schrankenstörung auf Höhe \\n  HWK4 und auf Höhe HWK7/ BWK1\\nINDENT - 10/2008 Liquor: 14 Zellen/ul, oligoklonale Banden positiv, IgG-Index 0.91\\nINDENT - 10/2008 VEP unauffällig, SEP nicht durchführbar\\nINDENT - 10/2008 virologisches Screening: unauffällig\\nINDENT - 10/2008 immunologisches Screening: unauffällig\\nINDENT - 10/2008 Mikrobiologie: unauffällig\\nINDENT - 10/2008 Rö-Thorax pa und lateral: altersentsprechender, normaler Herz-Lungenbefund. \\nINDENT - 10/2008 Schädel-CT ohne signifikante pathologische Veränderungen\\ntherapeutisch: \\nINDENT - St. n. Steroidstosstherapie 10.10.-13.10.2008 \\nINDENT - seit 07/2009 Avonex i.m. 1x/Woche[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, EM 2000, ED 2014, EDSS 1.0\\nINDENT Klinisch: nicht aktiv. Radiologisch aktiv (Lubin et al. 2014)\\nINDENT Anamnestisch: beschwerdefrei\\nINDENT Klinisch: leichte Rückstellsakkade beim Blick nach links, sonst kein fokal-neurologisches Defizit\\nINDENT Verlauf\\nINDENT mindestens 3 Schübe mit INO, Augenmotilitätsstörungen, Facialislähmung links, leichtem Hemi-Syndrom links\\nINDENT zuletzt 2019 Gangstörung, regredient unter Cortison \\nINDENT Diagnostik:\\nINDENT cMRI 27.03.19: im Vergleich zu 2016 zwei neue kleine Läsionen periventrikulär temporal und parieto-occipital links ohne Aktivität\\nINDENT cMRI 11/16: neu aufgetretener Entmarkungsherd Pedunculus cerebellaris inferior rechts\\nINDENT cMRI 07/16: Vorbestehende Entmarkungsherde sind teilweise deutlich regredient, es finden sich jedoch beidseits supratentoriell neu aufgetretene Entmarkungsherde mit Aktivitätszeichen frontal links und im linken Splenium.\\nINDENT Verdachtsdiagnose wohl bereits 2000 KSW gestellt mit OKB Liquor, negativen Borrelien, periventrikulären T2-Hyperintensitäten im MRI\\nINDENT Therapeutisch:\\nINDENT Avonex Juni 2015-2019, gestoppt wegen vermehrter Fatigue, zudem auch radiologische Aktivität (2016, 2019)\\nINDENT Gilenya Juli-August 2019, gestoppt wegen Leberwerterhöhung (GPT 219, GGT 644)[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig verlaufende Multiple Sklerose, Erstmanifestation 10/2010, Erstdiagnose 02/2012 mit/bei:\\nINDENT MRI-Schädel 01/2012: 5 T2-Läsionen supra- und infratentoriell, Läsion im Bereich des Lemniscus medialis sowie 16 mm messende Läsion im Verlauf des Nervus abducens\\nINDENT MRI cerebral und spinal 01/2013 und 04/2014, cMRI 01/2015: stabiler Befund, keine KM-Aufnahme\\nINDENT 03/2017 cMRI: 2 neuen Läsionen, keine KM-Aufnahme\\nINDENT EDSS 05/2017: 1.5\\nINDENT Unter Therapie mit Avonex Pen 1x/wöchentlich[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig remittierende Multiple Sklerose (RRMS), EDSS 2.0 (EM 1993, ED 2003)\\nINDENT Aktuell: diskrete Hemihypästhesie und Thermhypästhesie der rechten\\n      Körperhälfte und Gesichtshälfte, leichte Fingerfeinmotorikstörung links\\nINDENT Verlauf:\\nINDENT 1993 erster Schub, anamnestisch Schwäche des Beins rechts über 1 Monat\\nINDENT 03/2003 zweiter Schub mit Koordinationsstörung des rechten Beins und Feinmotorikstörung der rechten Hand\\nINDENT Residuum Hypästhesie der distalen Fingerendglieder (Dig. 1,2,3)\\nINDENT Therapeutisch:\\nINDENT 03/2004 Beginn der FTY720-Studie\\nINDENT seit 9.4.2010 FTY720 0.5mg 1x/Tag\\nINDENT Therapiestop Fingolimod am 04/18[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nHochgradiger V.a. entzündliche ZNS-Erkrankung ED 03.05.2019, EM 30.04.2019\\nINDENT ätiologisch: möglicherweise multiple Sklerose\\nINDENT anamnestisch: seit 4 Tagen aufsteigende Dysästhesie von den Füssen bis etwa T12, distal betont; St. n. Atemwegsinfektion vor einigen Tagen\\nINDENT klinisch: Dysästhesie sub Th12, Hypopallästhesie malleolar bds 7/8, Lagesinn und Temperatursinn erhalten,  keine Visusstörungen, leicht gesteigerte Reflexe (BSR und PSR bds) \\nINDENT diagnostisch\\nINDENT MRI BWS/HWS 03.05.2019: Intraspinale intramedulläre flau T2-hyperintense, kontrastmittelaufnehmende Läsion auf Höhe HWK1/HWK2 mit hochgradiger Verdacht auf Myelitis. Weitere T2-hyperintense intramedulläre Signalanhebungen auf Höhe BWK5 - BWK8 ohne Kontrastmittelaufnahme.\\nINDENT LP 03.05.2019: Zellzahl 11, Protein 0,565 g/l, OKB positiv (5 Banden)\\nINDENT Labor: AQP-4-Ak und Vaskulitis-Screening im Serum negativ\\nINDENT Urin-Status 03.05.2019: blande\\nINDENT cMRI vom 06.05.2019: Gliotischer Defekt des Crus posterior der Capsula interna links\\nINDENT Elektrophysiologie vom 07.05.2019: normale Tibialis-SEPs.\\nINDENT therapeutisch\\nINDENT Kortisonstoss mit Solu-Medrol 1g/d i.v. vom 04.05-08.05.2019[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nCerebrale FLAIR-Hyperintensitäten bislang ungeklärter Ätiologie, EM 07/2012, ED 02/2014, EDSS 0.0\\nINDENT Ätiologisch: Unklar, DD vaskulär, DD schubförmige Multiple Sklerose eher unwahrscheinlich\\nINDENT Klinisch/aktuell: nihil\\nINDENT Verlauf:\\nINDENT 08/2012 Anamnestisch Unteramschwäche beidseits über drei Tage\\nINDENT seit 09/2012 intermittierend stechende Muskelschmerzen und passagere Dysästhesien im Bereich beider Arme und Beine, an Frequenz und Dauer nicht zunehmend\\nINDENT Diagnostik:\\nINDENT 12/2012 MRI Gehirn und HWS: multiple periventrikulär betonte T2/FLAIR-Hyperintensitäten, kein Nachweis einer floriden Entzündung; MRI HWS unauffällig (nur schriftlicher Befund)\\nINDENT 12/2012 Neurographien: Medianus, Ulnaris, Suralis normal.\\nINDENT 01/2013 VEP: Normalbefund\\nINDENT 01/2013 Liquor (extern): 1 Zelle/ul, keine Schrankenstörung, Protein 418 mg/l, keine intrathekale IgG Synthese, Zellzahl 1/ul, Borrelien, Herpes simplex sowie VZV-Antikörper negativ\\nINDENT 2014 und 03/2016 Labor: Infektiologisches und immunologisches Screening normwertig.\\nINDENT 01/2014 MRI Gehirn und WS: In Anzahl leicht progrediente supratentorielle Marklagerläsionen, aktuell ohne KM Aufnahme, Keine infratentoriellen Läsioenen. Keine Läsion im Bereich des Myelons. \\nINDENT 03/2016 MRI Gehirn: Stationärer Befund zu 01/2014\\nINDENT 10.03.2016 CT Thorax (Spital Horgen): keine Lymphadenopathie, mehrere kleine unspezifische Noduli (ca. 2mm) a.e. Granulome \\nINDENT 03/2017 cMRI: unverändert\\nINDENT 04/2018 cMRI: unverändert\\nINDENT VEP und OCT 10/2018: Normalbefunde\\nINDENT Liquordiagnostik von 01/2019: unauffällig, keine intrathekale IgG Synthese, MRZ-Reaktion negativ\\nINDENT MOG AK im Serum 01/2019: negativ\\nINDENT 01/2019 cMRI: neue, jedoch nicht aktive demyelinisierende Läsion im Pons rechts, a.e Artefakt.\\nINDENT Therapie:\\nINDENT  01/2015-03/2019 Tecfidera [/INST]\\nDiagnosis:\\nschubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nEntzündliche ZNS-Erkrankung, möglicherweise Multiple Sklerose vom schubförmig-remittierenden Verlaufstyp (ED 12/2015 Spital Linth)\\nINDENT anamnestisch: aktuell seit heute stechende Schmerzen der Oberschenkel, zudem Kraftlosigkeit und Kopfschmerzen\\nINDENT klinisch: bei Eintritt und Austritt dissoziierte Sensibilitätsstörung sub Th10 bds. (Thermhypalgesie und Hyperästhesie), lebhaft auslösbare MER, Babinski-Zeichen bds. positiv, Urge-Symptomatik\\nINDENT MRI vom 07.07.2016: stationäre MS-Läsionen periventrikulär sowie subcortical frontal, keine pathologische KM-Anreicherung, bekannte intramedulläre Läsion auf Höhe BWK 9/10 im Funiculus anterior und lateralis ist etwas flauer abgrenzbar und nimmt kein KM auf, weitere kleine intramedulläre Läsion im Funiculus anterior auf Höhe BWK 5 ohne KM Anreicherung DD intramedulläre Läsion oder Artefakt\\nINDENT Liquor vom 08.07.2016: ZZ 3/ul, Protein 0.315 g/l; keine intrathekale Synthese von IgM, IgG und IgA, OKB negativ\\nINDENT bisheriger Verlauf:\\nINDENT 11/2015: Sensibilitätsstörung der linken Zungen- und Rachenhälfte, 3 Tage später Abducensparese rechts; vollständige Remission unter Solumedrol i.v.\\nINDENT 03/2016: Beinschwäche und -schmerzen, abgeschwächter Tonus mit fraglich positivem Babinski-Zeichen bds. \\nINDENT diagnostisch Spital Linth: \\nINDENT cMRI 21.03.2016: stationäre Demyelinisierungsherde mit partiell axonalem Substanzverlust ohne KM-Enhancement, keine neuen Herde \\nINDENT MRI WS 22.03.2016: fragliche geringe Signalalteration von 7 mm Durchmesser mit KM-Enhancement ventral im thorakalen Myelon auf Höhe BWK10/11\\nINDENT cMRI 12/2015: mindestens 5 supratentorielle Demyelinisierungsherde\\nINDENT MRI WS 12/2015: altersentsprechend normal\\nINDENT VEP mit pathologisch verzögerter Latenzzeit rechts\\nINDENT Liquorpunktion 12/2015: OKB negativ\\nINDENT Borrelien-Serologien negativ\\nINDENT therapeutisch: seit 23.06.2016 unter Fingolimod[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nImmunität gegen Hepatitis A/-B\\nINDENT St.n. vollständiger Hepatitis A/-B-Impfung\\nINDENT Dokumentierter Hepatitis B-Impftitier > 1000 IE/l[/INST]\\nDiagnosis:\\nnot enough info',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose mit vorherrschend schubförmigem Verlauf: Ohne Angabe einer akuten Exazerbation oder Progression\\nINDENT Anamnestisch: Ermüdung des rechten Beines, Thermhypästhesie der rechten Körperseite, Dysästhesien der rechten Körperseite (teils einschiessend), Lhermitte-Zeichen positiv, Fatigue, Drangsymptomatik \\nINDENT Klinisch: Thermhypästhesie der rechten Körperhälfte, leichte Ataxie im Finger-Nase-Versuch rechts, Lhermitte-Zeichen positiv \\nINDENT Diagnostik:\\nINDENT Lumbalpunktion: nie durchgeführt worden auf Wunsch des Patienten\\nINDENT MRI (11/2016): T2-hyperintense Läsionen periventrikulär bds., stationärer Befund\\nINDENT spinales MRI (11/2016): neue Läsion HWK5/6 rechts mit KM-Aufnahme. Läsionen HWS2 und BWK6 ohne KM-Aufnahme.\\nINDENT cMRI (12/2017): zwei neue Läsionen, eine mit KM-Aufnahme, ansonsten stabile Befunde\\nINDENT VEP (09/2017): normwertig\\nINDENT Labor (06/2016): JCV positiv (anamnestisch hoher Index)\\nINDENT Verlauf:\\nINDENT 2014: Kribbeln in den Beinen intermittierend. V.a. abends im Bett, mittags starke Müdigkeit\\nINDENT 06/2015 Schub mit Sensibilitätsstörungen der rechten Handfläche und Fühlsstörung beider Beine\\nINDENT 02//03-2016: Schub unter Copaxone\\nINDENT 05/2016: Schub unter Copaxone mit Kraftverlust im rechten Bein\\nINDENT 10/2016: Schub mit Fühlsstörung rechtsbetont an den Beinen\\nINDENT 02/2017: Schub unter Fumarsäure mit Gefühlsstörungen und Brennen im gesamten Körper\\nINDENT 07/2017: Schub unter IVIG mit Kraftverlust im rechten Bein mit starkem Brennen der rechten Körperseite\\nINDENT 12/2017: Schubereignis mit einschiessenden Dysästhesien und intermittierendem Kraftverlust des rechten Beines\\nINDENT 02/2018. Schubereignis mit Hypästhesie der Finger- und Zehenspitzen linksseitig\\nINDENT Therapie:\\nINDENT 12/2015 - 12/2016: Copaxone (Schübe)\\nINDENT 12/2016 - 03/2017: Dimethylfumarat (Schub und UAW: Verdauungsprobleme-Flatulane und Durchfall)\\nINDENT seit 03/2017: IVIG (Schubaktivität)\\nINDENT Erstgabe Ocrelizumab 01/2018\\nINDENT Mobilisierungschemotherapie mit Cyclophosphamid 2x2g/m2 KOF ab 23.11.18\\nINDENT Periphere Stammzellsammlung am 03.12.18 mit 12.28*10^6/kg KG[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n1. Multiple Sklerose a.e. primär progredient, EM 2011, ED 03/2015, EDSS 3.5\\nINDENT klinisch: nicht aktiv, radiologisch: nicht aktiv, Progression: nein (nach Lublin et al. 2013)\\nINDENT aktuell: im langfristigen Verlauf langsame Besserung der spastisch-ataktischen Gangstörung \\nVerlauf:\\nINDENT 1997 Episode mit aufsteigenden Sensibilitätsstörungen der Beine. Abklärungen erfolgten in der Neurologie USZ (LP, MRI, evozierte Potentiale), eine Diagnose wurde jedoch nicht gestellt \\nINDENT 1997-2011 Anamnestisch keine neurologische Symptomatik eruierbar\\nINDENT 2011-2016 langsam progrediente, rechtsbetonte spastisch-ataktische Gangstörung, distal betonte Pallhypästhesie und eingeschränktes Lageempfinden der unteren Extremität\\nDiagnostik:\\nBildgebung\\nINDENT 06.02.2015 MRI Wirbelsäule: Multietagere multiple T2 hyperintense Läsionen cervicothorakal, V.a. Gd-Aufnahme auf Niveau BWK 5 - BWK 7\\nINDENT 18.02.2015 MRI Gehirn: Multiple T2w- und FLAIRw-hyperintense supra- und infratentorielle Läsionen, passend zu einer demyelinisiernden Erkrankung. Vd. a. leichte Opticusneuritis links\\nINDENT MRI Schädel/WS 02/2016: multiple neue KM anreicherne Läsionen cerebral und spinal, teils ringförmig\\nINDENT 01/2017 MRI Kopf und WS: eine neue Läsion sowie progrediente demyelinisierende Plaque subzentral rechts. Regrediente Kontrastmittelanreicherung intrakraniell bei Rest-Kontrastmittelanreicherung um die demyelinisierende Plaque im Bereich der Pons paramedian links. WS: stationär\\nINDENT 09/2017 MRI Neuroachse: Unveränderte demyelinisierende Läsionen intrakraniell und spinal; weiterhin ohne Hinweis auf Aktivität; stationäre Myelonatrophie zervikal\\nINDENT 09/2018 MRI WS: Unveränderte demyelinisierende Läsionen des Myelons ohne Nachweis neuer oder aktiver Herde. Stationäre Myelonatrophie zervikal.\\nINDENT 02/2019 MRI Schädel: ausgedehnte Läsionen ohne Anhalt für neue oder aktive Herde\\nINDENT 10/2019 MRI Schädel: bekannte, extensive Darstellung Demyelinisierungsherde, kein Anhalt für neue oder aktive Herde   \\nLabor\\nINDENT Liquor 12.02.2015: ZZ 8/µl,  IgG Index 1.85, OKB positiv\\nINDENT 10/2016: FACS Analyse 4 Monate nach 1. Rituximab-Gabe komplette Depletion der CD20 pos. Lymphozyten\\nsonstige Untersuchungen\\nINDENT MEP 05/2015: Normale MEP-Untersuchung zum rechten Arm. Pathologische MEP Untersuchung zum linken Arm und beiden Beinen (die MEPs zum linken Bein sind nicht reproduzierbar).\\nINDENT Ganglabor 12/2016: Reduktion der maximalen Gehgeschwindigkeit (Timed-25-Foot-Walk: 5.1 s) und Ausdauer (6-Minuten-Gehtest: 476 Meter) \\nINDENT Ganglabor 04/2018: stabiler Verlauf im Vergleich zu 02/2016 der klinischen Steh- und Gehfähigkeit, der posturalen Standstabilität und der kinetisch getesteten Gehfähigkeit\\nTherapie:\\nINDENT 1 g Solu-Medrol 03.-05.03.2015\\nINDENT 2 g Solu-Medrol 27.-29.06.2015\\nINDENT 1 g Solu-Medrol 18.-20.09.2015\\nINDENT Rituximab 375 mg/kg KöF: 1. Gabe am 28.06.2016 (600 mg), 2. Gabe am 12.01.2017 (608 mg), 3. Gabe am 17.07.2017 (608mg), 4. Gabe am 24.04.2018 (607 mg), 5. Gabe am 09.10.2018 (607.5mg), 6. Gabe am 28.05.2019, aktuell 7. Gabe am 11.12.2019\\n2. A. e. unspezifische Lymphopenie\\nINDENT Lymphozyten (mikroskopisch) am 21.05.2015: 1.37 G/l\\nINDENT Lymphozyten (automatisch)10/2016: 1.08 G/l; 01/2017: 1.04 G/l; 07/2017: 0.87 G/l, 04/2018: 0.94 G/l\\nINDENT FACS-Analyse 05/2015: Normale Verteilung und relative Frequenz der Lymphozyten-Subpopulationen\\nINDENT FACS-Analyse 02/2016: Normale Verteilung und relative Frequenz der Lymphozyten-Subpopulationen\\n3. Migräne mit Aura\\nINDENT anamnestisch: seit dem Alter von 14.\\nINDENT semiologisch: Visuelle und sensible Aura,Übelkeit. Aktuell seit 2,5 Jahren kein Anfall mehr. Vorher 2-5 Mal /Jahr\\n4. MTP-1-Arthrose links, Tibialis posterior Insuffizienz Grad 1[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 12/2009, ED 09/2010), aktueller EDSS 0\\nINDENT - aktuell: beschwerdefrei\\nVerlauf:\\nINDENT - 12/2009 Parästhesien der Hände bds.\\nINDENT - 11/2011 stechende Hyperästhesie und Hyperpathie der Kopfhaut\\nINDENT - 07/2012 sensibles Querschnittssyndrom sub Th6 mit Kribbelparästhesien und \\nHypästhesie, Kribbelparästhesien der Fingerspitzen bds. seit \\nDiagnostik:\\nINDENT - 09/2010 MRI Kopf und Spinal (Spanien): multiple nicht KM-aufnehmende Herde\\nINDENT - 09/2010 Lumbalpunktion (anamnestisch pathologischer Befund, schriftlicher \\nBefund nicht vorliegend)\\nINDENT - 02/2013 cMRI: Multiple, demyelinisierende Läsionen im periventrikulären Marklager und subcortikal. Eine periventrikuläre Läsion auf der rechten Seite am lateralen Rand des Corpus callosum nimmt Kontrastmittel auf.\\nINDENT - 10/2013 MRI cerebral/ spinal: Im Myelon zeigen sich 3 zervikale und 4 thorakale Läsionen, grösste Läsion auf Höhe HWK2 umfasst nahezu die dorsalen 2/3, ist ödematös und weist ein diskretes Enhancement auf. Zwei neu aufgetretene Herde einer mit Kontrastmittelenhancement subependymal links am Truncus des Corpus callosum, der zweite ohne Aktivität im Forceps minor links. Flaue Läsion in der Medulla oblongata mit fraglichem Enhancement. Ansonsten intrakraniellen Herde stationär ohne Aktivität. \\nTherapie:\\nINDENT - Solumedrol 1g i.v. über 5 Tage 07/2012\\nINDENT - Copaxone seit 08/2012 \\nINDENT - Gilenya vom 13.01.2014 bis Ende Mai 2015 \\nINDENT - Rebif seit 13.07.16[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nVd.a. autoimmun-entzündliche ZNS-Ekrankung, am ehesten einer schubförmig-remittierenden multiplen Sklerose entsprechend (EM 1997):\\nINDENT aktuell Vd. a. zweiten Schub (Erstereignis 1997): \\nINDENT seit 4-5 Wochen Schwäche re Bein und Arm; klinisch: leichtgradige Tetraparese rechtsbetont, Hypästhesie an beiden Fussohlen, zerebelläre Ataxie, Blickrichtungsnystagmus re>li,  Finger-Nase-Versuch dysmetrisch bds (li> re) Knie-Hacke-Versuch dysmetrisch bds. Links Dys-und Bradydiadochokinese, EDSS 3.0.\\nINDENT aktenanamnestisch: \\nINDENT 1997 (Dr. Riederer): bei rez. Schwindelattacken mit Bewusstlosigkeit und motorischen Störungen am li Bein (im Verlauf komplett regredient) Vd.a. erster Schub einer Enzephalomyelitis disseminata \\nINDENT 2000 (Dr. Riederer): Dg einer MS, zurzeit ohne Hinweise für eine Reaktivierung\\nINDENT diagnostisch:\\nINDENT 1997 cMRI: multiple Signalveränderungen periventrikulär bds., vereinbar mit Entmarkungen\\nINDENT 2000 cMRI: multiple Signalveränderungen, a.e. unverändert im Vergleich zur Voruntersuchung \\nINDENT 03/2014 Rö-Thorax: keine AP für mediastinale oder intrapulmonale Raumforderungen. Leicht degenerative Veränderungen der BWS. \\nINDENT 03/2014 Liquor: gestörte Blut-Hirn-Schranke (Albumin-Quotient 22.0 x10^-3, Albumin 1070 mg/l); Hinweise auf intrathekale IgG-Synthese (IgG-Index 0.82); ZZ=15/ul, Glukose und Laktat normwertig; OKBs pos.\\nINDENT 21.3.2014 MRI der Neuroachse: multiple demyelinisierende Läsionen zerebral und spinal mit KM-Enhancement\\nINDENT 2.4.2014 MRI Gehirn (nach Solu-Medrol Stosstherapie): Verglichen mit der Voruntersuchung vom 21.03.2014 deutliche regrediente KM-Aufnahme der bekannten multiplen MS Plaques mit geringem Restbefund. Keine neuen Plaques.   \\nINDENT 03/2014 laborchemisch: Vaskulitis-Screening, anti-NMO, HIV, HCV, TSH, Folsäure, Holotranscobalamin, CRP, Leber-/Niere-Werte, Glukose, Eletkrolyte, Blutbild, Gerinnung unauffällig; 25-Hydroxy-Vitamin D mit 7.5 µg/l erniedrigt, Anti-HBs positiv (135 IE/l);Lues-Serologie neg., Borrelien Serologie: IgG im Liquor und Serum pos., IgM neg (Hinweis auf eine abgelaufene Borrelieninfektion)\\nINDENT therapeutisch:\\nINDENT 03/2014 Solu-Medrol 1g/d über 5 Tage vom 26.3-30.3.14[/INST]\\nDiagnosis:\\nschubförmig-remittierende Multiple Sklerose (RRMS)\\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nKlinisch isoliertes Syndrom bei Retrobulbärneuritis des rechten Auges, EM 10/2015, ED 10/2015\\nINDENT anamnestisch: seit Anfang 10/2015 Verschwommensehen beidseits und sowie Bulbusbewegungsschmerz rechtes Auge, Rotentsättigung des rechten Auges, Verschwommensehen beidseits, RAPD rechts, Grippaler Atemwegsinfekt mit Husten, Schupfen, Kopf- und Halsschmerzen und teils subfebrilen Temperaturen.\\nINDENT klinisch: aktuell VOD 0.75, bds. verplumpter Einbeinsprung, Fatigue, EDSS 1.5.\\nINDENT diagnostisch:\\nINDENT MRI Gehirn 15.10.2015: N. opticus rechts im Seitenvergleich verdickt mit minimal erhöhtem Signal in den T2-Bildern sowie leichtem Enhancement nach KM-Gabe. Cerebral einzelne demyelinisierende Läsionen im Marklager (mehrere sehr kleine supratentoriell teils periventrikulär und eine etwas grössere infratentoriell) ohne pathologisches KM-Enhancement.\\nINDENT Lumbalpunktion 16.10.2015: Zellzahl 3/ul, Totalprotein leicht vermindert, intrathekale IgG Synthese, OKBs im Liquor pos. AQP4 IgG und MOG IgG neg.\\nINDENT Vaskulitisscreening neg.\\nINDENT Folsäure, Vit. B12, Vit D3 normwertig.\\nINDENT Virologische Serologie HIV neg., CMV/EBV/HSV/VZV je IgG pos., IgM neg.\\nINDENT Mikrobiologische Serologie: Borrelia burgdorferi 20.10.2015 IgG neg. IgM grenzwertig -> Wiederholung 23.10.2015 IgG neg., IgM pos. -> Serologie aus Liquor IgG und IgM neg.\\nINDENT MRI Gehirn und WS 29.12.2015: Aktuell kein Anhaltspunkt für eine Neuritis Nervi opticiim übrigen stationärer Befund. Kein Anhaltspunkt für Läsionen im Myelon.\\nINDENT therapeutisch:\\nINDENT Kortisonstosstherapie Soulmedrol i.v. 1g/d 20.-24.10.2015\\nINDENT Therapiebeginn mit Copaxone (Glatirameracetat) geplant[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, EM 5/2015, ED 1/2016, EDSS 1.0\\naktuell:\\nINDENT intermittierende Kribbelparästhesien in beiden Händen und Füssen, ansonsten beschwerdefrei\\nVerlauf: \\nINDENT 05/2015: Diplopie (Motilitätseinschränkung OD M Rectus superior) und Schwindel mit Blickrichtungnystagmus nach re>li.\\nINDENT 10/2015: Kribbelparästhesien am linken Arm und Bein\\ndiagnostisch: \\nLabor: \\nINDENT Liquor 05/2015: OKBs positiv\\nBildgebung:\\nINDENT 07/2015 MRI cerebral & spinal: teils geringe Grössenregredienz einzelner supratentorieller Läsionen, ansonsten unveränderte Darstellung;  keine KM-Aufnahme.\\nINDENT 01/2016 MRI cerebral & spinal: multiple Läsionen supra- und infratentoriell, teils regredient, teils unverändert, neue Läsionen im Gyrus frontalis superior rechts und dorsal pontin rechts. Keine KM-aufnahme.\\nINDENT 10/2016 MRI cerebral & spinal: neue Läsionen, KM-Anreicherung in drei Läsionen (frontal, Pons paramedian rechts). \\nINDENT 04/2017 MRI cerebral & spinal: supratentoriell neue und teils grössenprogrediente Läsionen, partiell mit vermehrter Kontrastanreicherung sowie eine neue Läsion im Mesencephalon / Crus cerebri rechts. Spinale multiple neue Läsionen teils auch mit punktförmiger Kontrastanreicherung bei Th5/6 sowie Progredienz einer vorbestehenden Läsion auf Höhe TH 10. \\nsonstige Untersuchungen:\\nINDENT VEP 06/2015: normale VEPs beidseits, keine Seitendifferenz, keine Latenzzeitverzögerungen.\\ntherapeutisch: \\nINDENT 05/2015: Cortisonstoss-Therapie für 5 Tage\\nseit 06/2016: Therapie mit Avonex[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, ED 07/2016\\nINDENT Therapie: Betaferon[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nChronisch-demyelinisierende ZNS-Erkrankung, EM 01/2016, ED 02/2018\\nINDENT ätiologisch: a.e. schubförmige Multiple Sklerose (McDonald Kriterien 2010 erfüllt, Ausschlussdiagnostik noch nicht komplettiert)\\nINDENT anamestisch: \\nINDENT aktuell: ungerichteter Schwindel, Doppelbilder bei Blick nach rechts, Nausea am 01.03.2018, Fazialisparese links seit 03.03.2018\\nINDENT Sommer 2017: pins-and-needles auf halber Körperseite für ca. 1-2 Tage\\nINDENT Januar 2016: Dysarthrie, Koordinationsstörungen, Fatigue für 2 Tage\\nINDENT klinisch: Komplexe Okulomotorikstörung mit INO links, Trochlearisparese links, Blickrichtungsnystagmus horizontal und vertikal, Fazialisparese links (a.e. nukleär)Reflexbetonung rechts.\\nINDENT diagnostisch:\\nINDENT cCT-Angio 02.03.2018: keine Blutung keine Gefässstenose\\nINDENT cMRI vom 02.03.2018: Multiple FLAIR Hyperintensitäten supratentoriell (juxtakortikal, periventrikulär, Marklager), am linken Hinterhorn (12mm) mit KM Aufnahme, Gyrus frontalis sup. und medius rechts 9mm mit KM Aufnahme, Capsula interna links (7mm), Pons links (7mm), weitere Läsionen frontal, temporal, parietal links, okziptal beidseits. Nervi optici regelrecht.\\nINDENT Liquor vom 02.03.2018: klar, Protein 0,28 g/l und Zellzahl 2/µl regelrecht, OKB ausstehend\\nINDENT Labor extern Stadt Spital Waid: Serologie Aquaporin 4 (USZ) CMV (USZ) HSV Typ 1 und 2 (USZ). HZV (USZ). VZV (USZ), Borellien und Lues im Liquor (UZH)\\nINDENT Vaskulitisscreening, Vitamin D und B12 ausstehend \\nINDENT therapeutisch: \\nINDENT Solumedrol 1g i.v 02-06.03.2018 (Stadtspital Waid)[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 12/2006, ED 06/2015), EDSS 3.0\\nAktuell (02/2019): Klinisch nicht aktiv, radiologisch aktiv,  Progression ja (nach Lublin et al. 2013)\\nINDENT Klinisch: Residuelle periphere Fazialisparese links (Stirnrunzeln, Signe des cils, verminderter Augenschlag, Mundast), Kribbelparästhesien,  positives Babinski-Zeichen bds., erschöpfliche Fusskloni bds. (2-3), leichte Ataxie beim Finger-Nase-Versuch links, leicht schwankender Romberg-Versuch, positiver Unterberger Tretversuch nach links sowie sehr unsicherer Seiltänzergang. Blasenentleerungstörung.\\nINDENT Verlauf:\\nINDENT 02/2007 Optikusneuritis links\\nINDENT 2009 Periphere Fazialisparese links, unvollständig regredient\\nINDENT 09/2014 Kribbelparästhesien in beiden Füssen, nach 4-5 Monaten unvollständig regredient\\nINDENT 08/2016: Kribbelparästhesien und Taubheitsgefühl des gesamten rechten Beines \\nINDENT Diagnostisch:\\nINDENT 12/2006 MRI Hirn: Aktenanamnestisch unauffällig (s. Bericht Augenklinik 08.02.2007)\\nINDENT 12/2006 VEP: Links Leitungsverzögerung und reduzierte Amplitude (s. Augenklinik 08.02.2007)\\nINDENT 05/2015 MRI Hirn und Myelon: Multiple supra- und infratentorielle T2 hyperintense Läsionen ohne Kontrastmittelaufnahme. Langstreckige T2 hyperintense Läsionen vom Dens bis zur Deckplatte HWK 5 reichend. Thorakale Myelonläsion zentral auf der Höhe BWK3/BWK 4. Alle ohne Aktivitätszeichen.\\nINDENT 11/2015 MRI cerebral/spinal: Stationärer Befund, keine KM-Aufnahme\\nINDENT 05/2015 SEP: Beidseits (li>re) verzögert\\nINDENT 06/2015 Liquor: ZZ 7/ul, OKB im Liquor positiv, im Serum negativ, IgG-Index 0,86 \\nINDENT 06/2015 Virologisches, immunologisches, infektiologisches und metabolisches Screening unauffällig\\nINDENT 24.07.2015: Anti-NMO (AQP4) Ig negativ (USZ)\\nINDENT JCV stratify test 11/2015\\nINDENT 06/2016 MRI zerebral/spinal: Stationärer Befund, keine KM-Aufnahme.\\nINDENT Therapeutisch:\\nINDENT Tecfidera vom 22.08.2015 - 01/2016 (pausiert wegen Kinderwunsch)[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose mit Residuen, EM 2000, ED 2006, EDSS 6.5\\nINDENT Aktuell:\\nINDENT Klinisch: nicht aktiv, radiologisch: aktiv, Progression: nein (nach Lublin et al. 2013)\\nINDENT Klinischer Verlauf:\\nINDENT 2000 EM mit Doppelbilder für zwei Monate\\nINDENT 09 - 10/2007 akute Verschlechterung der Gehfähigkeit, komplette Erholung\\nINDENT Seit 10/2009 rasch progrediente Verschlechterung der Gehfähigkeit\\nINDENT 07/2010 Schub mit Verschlechterung der Gehfähigkeit, Kribbelparästhesien der linken Hand, Gefühlsstörungen sub Th4\\nINDENT 08/2010 erneute Cortisonstosstherapie bei Koprostase, reduzierter Gehfähigkeit und Sensibilitätsstörungen der linken Hand\\nINDENT 09 - 10/2010 Schub mit Gangstörung, Hyp- und Dysästhesie ab Gesäss kaudalwärts nach Harnwegsinfekt, teilweise Regredienz der Symptome unter 5-tägiger Cortisonstosstherapie\\nINDENT Diagnostisch:\\nINDENT 12/2006 Liquor: 3 Zellen, OKB positiv, IgG-Index 0.68, intrathekale Ig-Synthese\\nINDENT 10/2011 JCV-Test positiv; Pt informiert, möchte Tysabritherapie fortsetzen\\nINDENT 09/2013: JCV-positiv, Index 1.064, 03/2014 Index: 1.066, 09/2014: Index: 0.898\\nINDENT 11.12.2014: cMRI: Kein Hinweis auf neue Läsionen\\nINDENT MRI zerebral und spinal 10/2016: Eine neu aufgetretene Läsion auf Höhe C4, die übrigen intramedullären und intrakraniellen Läsionen unverändert\\nINDENT Ganglabor 15.12.2016: Stark spastisches Gangbild mit deutlichen Einschränkungen der Gangfunktion\\nINDENT MRI Schädel und WS 27.04.2017: Stationärer Befund\\nINDENT MRI Schädel 11/2017: Annähernd stationäre Läsionslast, kein Hinweis für aktive Läsionen\\nINDENT Ganglabor 19.12.2017: Jeine deutliche Verbesserung unter Fampyra\\nINDENT Neuropsychologie 24.01.2017: Unverändert zu Voruntersuchungen\\nINDENT MRI Neuroachse 08/2018: Eine neue Gd-spinale Läsion, cerebral unveränderte Läsionslast\\nINDENT Therapeutisch:\\nINDENT 10/2007 - 09/2009 Rebif 3x44mcg/Woche \\nINDENT 09/2009 - 12/2009 Rebif wegen Leukozytopenie pausiert \\nINDENT 12/2009 - 02/2010 Rebif  3x22mcg/Woche (Absetzen wegen erneuter Blutbildveränderungen)\\nINDENT 03/2010 - 08/2010 Copaxone s.c. 1x/Tag\\nINDENT Erneute Umstellung auf Rebif 09/2010- 10/2010 (Wunsch des Patienten)\\nINDENT 10/2010 - 01/2011 Uvamin (Nitrofurantoin) und Acimethamin\\nINDENT 11.10.2010 - 12/2014 Tysabri 300mg i.v. alle 4 Wochen (beendet wegen PML-Risiko)\\nINDENT 01/2015 - 01/2018 Tecfidera (pausiert vom 31.12.2016 - 10.01.2017 aufgrund Leuko- und Lymphopenie)\\nINDENT Seit 03/2019 Rituximab[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nLumboradikuläres Reizsyndrom mit sensorisches Ausfallsyndrom S1 rechts\\nINDENT Fehlender ASR rechts, Hyposensibilität Dermatom S1 rechts\\nINDENT MRI LWS 23.5.13, extern/Medizinisch Radiologisches Institut Bahnhofplatz: Kompression der Nervenwurzel S1 rechts\\nINDENT Periradikuläre Steroidinfiltration S1 rechts am 23.5.13 (Medizinisch Radiologisches Institut Bahnhofplatz)[/INST]\\nDiagnosis:\\nnot enough info \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose, schubförmige Verlaufsform (EM 03/2015, ED 05/2015), EDSS 1.5\\nAktuell\\nINDENT subjektive Beschwerdefreiheit, residuelle Kribbelparästhesien der Unterschenkel\\nKlinisch: \\nINDENT residuelle Visusminderung, sonst unauffälliger neurologischer Befund\\nVerlauf: \\nINDENT seit 2014: diskrete Visusminderung im linken Auge\\nINDENT 03/2015: Schub mit Kribbelparästhesien Unterschenkel bds., MER UEX rechts gesteigert, Stand- und Gangataxie\\nDiagnostik:\\nLabor:\\nINDENT Labor/Immunologie: unauffällig\\nINDENT Serologie: HSV 1+2 Ig erhöht, IgM grenzwertig (Serum), im weiteren kein Erregernachweis\\nINDENT Liquor 27.04.2015: ZZ 6/µl, OKB positiv\\nBildgebung:\\nINDENT MRI LWS 07.04.15: Solitäre T2-hyperintense, inhomogen kontrastmittelaufnehmende Läsion (9 mm Durchmesser) im Myelon auf Höhe des BWK 11.\\nINDENT MRI Gehirn und WS 21.04.2015: Mehrere supratentorielle demyelinisierende Läsionen des Hirnparenchyms, eine davon im Forceps major rechtsseitig mit KM-Anreicherung. Vorbeschriebene bekannte demyelinisierenden Läsion des thorakalen Myelons auf Höhe BWK11\\nINDENT MRI Gehirn und WS 01/2016: Neu / besser demarkierte Läsion Höhe HWK6/7 linksseitig posterior sowie neue Läsion pericallosal am Vorderhorn linksseitig, keine KM-Aufnahme.\\nINDENT cMRI  07/2016: Eine neu aufgetretene FLAIR hyperintense Läsion im Marklager links temporal mit KM-Enhancement.\\nINDENT MRI WS 07/2016: Im Verlauf kein relevanter Befundwandel. Keine neu aufgetretenen demyelinisierende Läsionen. kein pathologisches KM-Enhancement.\\nINDENT 02/2017 MRI Neuroachse: stabiler Befund\\nINDENT 07/2017 cMRI: stationärer Befund. Bei Bewegungsartefakten etwas eingeschränkte Beurteilbarkeit, keine KM-Aufnahme\\nINDENT 08/2017 spinales MRI: Unverändert vorbestehenden Läsionen auf Höhe C6/7, sowie T11 ohne Anzeichen einer aktiven Läsion.\\nINDENT 08/2018 cMRI: eine neue demyelinisierende Läsion im frontalen Marklager links, keine KM-Aufnahme, ansonsten stationäre Befunde\\nsonstige Diagnostik:\\nINDENT 08/2017 VEP: normale, seitenvergleichbare P100. Stabiler Befund\\nINDENT 08/2017 Ganzfeld-ERG:  normale, seitenvergleichbare skotopisch eund photopische Antworten bds.\\nINDENT 08/2017 multifokales Elektroretinogramm (61 Hexagone): normale, seitenvergleichbare P1 Amplituden und Gipfelzeiten ohne fokale Störungen bds. Im Vgl. zu 2016 stabil bis verbessert\\nTherapie:\\nINDENT Solumedrol 28.04.2015-02.05.2015\\nINDENT Copaxone seit 30.07.2015\\nHypothyreose, ideopathisch\\nINDENT derzeitige Therapie: Thyroxin 75µg 1-0-0[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nV.a. entzündliche ZNS- Erkrankung (EM 10/2012)\\nINDENT Klinisch: Pallhypästhesie bds.\\nINDENT diagnostisch:\\nINDENT - 11/12 MRI-Schädel: multiple zerebrale T2-Hyperintensitäten im peri - und paraventrikulären Marklager und im Pons zentral sowie im Crus pontis rechts\\nINDENT - 12/12 MRI spinal: Multiple T2-hyperintense Läsionen im Bereiche des zervikalen sowie des thorakalen Myelons und auch des Pons, die mit demyelinisierenden inaktiven Herden vereinbar sind. Fokale links medio laterale Diskushernie auf Höhe der BWK 6-7mit leichtgradiger Einengung des Spinal-kanals aber ohne Kompression neuraler Strukturen. Nebenbefundlich Hämangiom im BWK 7. \\nINDENT - 12/12 Liquor: Zellzahl 1/ul, IgG-Index erhöht, OKB ausstehend\\n        - 12/12 Virologie unauffällig, Bakteriologie negativ.[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose mit sekundär progredientem Verlauf seit ca. 2004 (EM 1983, ED 1996)\\nklinisch:\\naktuell spastische Hemiparese links, stark eingeschränkte Gehstrecke (Rollator, Rollauto für längere Strecken ), Miktionsstörung, Fatigue-Syndrom, Abduzensparese rechts\\nletzter eindeutiger Schub 2001, 1983 Neuritis optici bds., 1996 sensibler Querschnitt Th5, seit 2004 zunehmende Gehbehinderung (04/2007 EDSS 5.5), deutliche Verschlechterung nach Patellafraktur 2014, seitdem Ausgangniveua nicht erreicht\\nbildgebend:\\n2005 MRI cerebral sowie HWS und BWS: Cerebral alte Läsion ohne KM-Anreicherung, spinal werden aktive Herde auf Höhe C4 und Th1/2 beschrieben.\\n01/2006 Kontroll-MRI spinal ohne aktive entzündliche Läsionen. Alte Läsionen sowie eine Verschmächtigung des Rückenmarks auf Höhe C2/3.\\ntherapeutisch:\\n2004 Methylprednisolon oral, Beginn mit 500 mg, schrittweise Reduktion über 3 Wochen. Darunter keine Besserung des Zustandsbildes\\nkeine immunmodulatorische Basistherapie \\nINDENT Eine Reha ist nötig um weiterer Immobilisierung entgegenzuwirken und eine Verbesserung der Gehstrecke zu erreichen, die Spastik adequat zu behandeln sowie Copingstrategien zu entwickeln. (s. Einzelpunkte). Bei Sekundär progredienter MS sind die medikamentösen Behandlungsmöglichkeiten sehr eingeschränkt. Die Rehabilitation ist eine der wichtigsten Massnahmen um einer Immobilisierung und vollständigen Rollstuhlpflicht entgegenzuwirken.[/INST]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nINDENT 39-jährige Patientin mit primärer Sterilität seit 15 Jahren (1998)\\nINDENT Multiple Sklerose, schubförmiger Verlauf mit Residuen (ED: 9/2004)\\nINDENT Beim Partner Verdacht auf Subfertilität bei hypo- bis normogonadotropem Hypogonadismus, Status nach off label use Clomifen 50 mg jeden 2. Tag und anschliessender probatorischer Spermienaufbereitung[/INST]\\nDiagnosis:\\nnot enough info \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 2002?/12/2004, ED 5/2009)\\n - aktuell: keine Beschwerden, keine Symptome; EDSS 0\\n - Verlauf:\\nINDENT - 2002 V.a. Guillain Barré Syndrom\\nINDENT - 12/2004  Optikusneuritis links, komplette Remission\\nINDENT - 08/2007 Sensomotorische Parese linker Arm für 2 Wochen \\nINDENT - 05/2009 sensibles Hemisyndrom links, Urge-Inkontinenz, Fatigue\\n - Diagnostisch:\\nINDENT - 08/2007 MRI Schädel + spinal  multiple T2 Läsionen supratentoriell, keine spinalen   Läsionen,\\n  keine Gd-Aufnahme\\nINDENT - 08/2009 MRI Kopf, HWS, BWS: 2 neue, nicht Gd-anreichernde Läsionen infratentoriell \\n  Cerebellum rechts und spinal Höhe BWK9\\nINDENT - 4.10.2010 MRI Gerhirn+HWS+BWS: im wesentlichen unveränderter Befund mit multiplen\\n   kleinen T2 Läsionen supratentoriell\\nINDENT - 01/2005 Liquor: positive oligoklonale Banden und Zellzahlerhöhung \\nINDENT - 10/2009 Liquor: 4 Zellen/µl, IgG-Index 0.82, Gesamtprotein 483 mg/l, OKB positiv\\nINDENT - 11/2009 VEP und SEP: normal\\nINDENT - 1/2010 Urologisches Konsil: intermittierend Harnblasenentleerungsstörung mit \\n  geringer Urininkontinenz\\nINDENT - 2/2010 NPSY: mittelschwere mnestische Defizite DD iR Fatigue/Depression\\nINDENT - MRI zerebral und spinal 10/2011: Multiple supratentorielle MS- Plaques, im Wesentlichen \\n  stationär zur letzten Voruntersuchung. Keine aktiven Plaques. Fraglich eine MS Plaque auf\\n  Höhe BWK 9, ohne KM- Enhancement. \\n - Therapeutisch:\\nINDENT - 12/2009-9/2010 Rebif 44µg s.c; Umstellung wegen grippalen NW, Fatigue, Depression\\nINDENT - 10/2010-1/2011 Copaxone 20 mg s.c. täglich;  abgesetzt wegen rezidivierenden\\n   fraglichen SPIRS \\nINDENT - 05/2011: Gilenya 0.5 mg/die\\nVd.a. Refluxbedingte Reizhustensymptomatik (ORL-Abklärung 09/2011 USZ)\\nINDENT - DD: Vocal cord dysfunction  [/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSekundär progrediente Multiple Sklerose (EM 1998, ED 1999), EDSS 7.0\\nINDENT aktuell: klinisch nicht aktiv, radiologisch aktiv, Progression seit 2010 (nach Lublin et al. 2013)\\nINDENT klinisch: Bein und linksbetonte Tetraparese, cerebelläres Syndrom, Fatigue, Urgesymptomatik \\nINDENT Verlauf:\\nINDENT 04/2013 50-100 m ohne Hilfe, Beginn Gehstocknutzung\\nINDENT 09/2014 Beginn Rollatornutzung und Rollstuhlnutzung, Gehstrecke mit beidseitiger Gehhilfe 20 m\\nINDENT 01/2019 Elektrorollstuhl\\nINDENT Diagnostik:\\nINDENT Lumbalpunktion vom 20.05.1999: Zellzahl 14ul, Oligoklonale Banden unklar. Virologische Untersuchung (CMV, VZV, HHV-6, HSV, Enteroviren) negativ. Toxoplasma gondii PCR negativ. Borrelien-Serologie negativ.\\nINDENT VEP vom 20.05.1999: beidseits pathologische Latenzen\\nINDENT Röntgen Thorax vom 20.05.1999: keine Hinweise auf Sarkoidose\\nINDENT cMRI 29.05.1999: Multiple cerebrale Läsionen mit Kontrastmittelanreicherung\\nINDENT 10/2012: JC-Virus pos.\\nINDENT cMRI 10/2012: stabil zu 04/2010\\nINDENT MRI cerebral und spinal 21.02.2014: neue Kontrastmitteaufnehemnde Läsionen spinal und cerebral im Vergleich zu 10/2012\\nINDENT MRI Neuroachse: 06/2019: multiple neue Läsionen mit Kontrastmittelaufnahme\\nINDENT Therapie:\\nINDENT 05/2010 Rebif bis 01.01.2014 \\nINDENT 09/2014 bis 12/2018 Gilenya\\nINDENT Aminopyrimidin seit 10/2013 10 mg 1-1-0[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (ED 01/2013), EDSS 0\\nAktuell: klinisch nicht aktiv, radiologisch aktiv, keine Progression (nach Lublin et al. 2013)\\nINDENT Bulbusbewegungsschmerz links, tritt öfter bei Stress auf\\nVerlauf: \\nINDENT 2010 Taubheitsgefühl beider Beine, sequentiell auftretend, positives Lhermitte-Zeichen, DD 1. Schub\\nINDENT 12/2012: Abduzensparese rechts\\nINDENT 11/2014: intermittierendes Taubheitsgefühl des kleinen Fingers bds. (re>li) ohne radiologische Korrelat\\nINDENT 12/2015: Bulbusbewegungsschmerz links mit Schleiersehen, keine Farbentsättigung ohne radiologisches Korrelat\\nINDENT 09/2016: Optikusneuritis links mit Verschwommensehen links \\nINDENT Diagnostisch:\\nLabor:\\nINDENT Liquor vom 20.12.2012: Zellzahl 13/ul, IgG 48.2 mg/l, OKB positiv\\nINDENT Autoantikörper- und Infektserologie unauffällig, HoloTc und Folsäure normal\\nINDENT AqP4-AK und MOG-AK negativ\\nINDENT JCV-Status negativ 09/2016\\nINDENT FACS-Analyse 7/15: zusammenfassend zeigt sich im peripheren Blut eine in der Relation prominente NK-Zellpopulaton mit 82% der Lymphozyten (absolut ~0.59 G/l), am ehesten bedingt durch die therapiebedingte Sequestrierung der Lymphozyten im Lymphknoten. Eine klonale B- Zellpopulation ist nicht nachweisbar\\nBildgebung:\\nINDENT 01/2013 Röntgen-Thorax: Normalbefund\\nINDENT MRI spinal 01/2013: im zervikalen und thorakalen Myelon demyelinisierende Läsionen ohne KM-Aufnahmen\\nINDENT MRI cerebral und spinal 06/2013: neue, winzige Läsion subependymal des Ventrikeltrigonums am Vorderrand der Forceps major rechts, ansosnsten stationärer Befund\\nINDENT cMRI 04/2015: stationärer Befund\\nINDENT cMRI 12/2015. stationärer Befund\\nINDENT MRI cerebral/ spinal 02/2016: stationäre Läsionslast, keine MK-Aufnahmen\\nINDENT cMRI 08/2016: stationärer Befund, keine neuen Läsionen, keine KM-Aufnahmen\\nINDENT cMRI 29.09.2016: minimale KM-Anreicherung Nervi optici links.\\nINDENT cMRI 30.06.2017: neue Läsion im posterioren Drittel des Corpus callosum rechts, sonst stationäre Läsionslast cerebral wie spinal, aktuell ohne Anhaltspunkt für aktive Läsionen. \\nINDENT cMRI 11/2017: eine neue aktive, schrankengestörte Läsion angrenzend im Bereich des linken Seitenventrikels posterolateral subependymal.\\nINDENT cMRI 04/2019: eine neue Läsion\\nTherapeutisch:\\nINDENT initial Rebif 02/2013, wegen Unverträglichkeit (lokale Reizung) sistiert\\nINDENT 03/2014 - 10/2016 Gilenya abgesetzt wegen Schub\\nINDENT Steroidpulstherapie vom 16.-18.12.2015\\nINDENT Steroidpulstherapie vom 29.09.-03.10.2016\\nINDENT 12/2016 - 05.02.2018 Tecfidera, abgesetzt bei Schwangerschaft\\nINDENT Wiederbeginn Tecfidera seit 28.07.2019[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 11/13, ED 1/2017) EDSS 1.5\\nklinisch:\\nINDENT  residuelle Visusstörung links (links 0,9, rechts 1) 06.03.18\\nVerlauf: \\nINDENT 04.11.13: Retrobulbärneuritis links mit Visusverlust, Fingerperimetrie links eingeschränkt, deutliche RAPD mit residueller Visusstörung links (Farbwahrnehmung, Visus 0.8 links)\\ndiagnostisch:\\nBildgebung\\nINDENT cMRI Gehirn vom 3.01.2017 neu aufgetretene Läsion posterior im Truncus / Splenium corporis callosi links mit subependymal perivenöser Ausdehnung.\\nINDENT cMRI Wirbelsäule vom 3.01.2017: stationäre Befunde, 1 Läsion auf Höhe HWK 5\\nINDENT cMRI 12/2017: neue Gd- Läsion des Gyrus angularis rechts\\nLabor\\nINDENT Liquor 5.11.13: oligoklonale Banden positiv, Zellen 12/ul, IgG-Index 0.7\\ntherapeutisch:\\nINDENT Rebif seit 12/2013 44ug 3/ Woche\\nINDENT Erstgabe Gilenya® am 05.03.2018[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM vermutlich 2007; ED 10/09), EDSS 2.0\\nINDENT Aktuell: klinisch nicht aktiv, radiologisch aktiv, keine Progression (nach Lublin et al. 2013)\\nINDENT Klinisch: Kein fokal-neurologisches Defizit. Mittelgradige Fatigue, eingeschränkte Gehstrecke 500-1000m\\nINDENT Verlauf: \\nINDENT 2007 anamnestisch Kribbelparästhesien Bein rechts\\nINDENT 02/2008 anamnestisch zwei Wochen anhaltende Schmerzen beim Blick nach rechts, Blitze-Sehen beim Blick nach rechts, keine Visusminderung\\nINDENT 01/2009: anamnestisch Taubheitsgefühl Arm und Bein links (n. Mononucleosis infectiosa)\\nINDENT 09/2009 Retrobulbärneuritis rechts, komplett regredient\\nINDENT 02/2010 Schub mit Dysästhesien und leichter Hypästhesie des rechten Beins ab Th 8, Dysästhesien im Versorgungsgebiet des Trigeminusstirnasts links, Reflexsteigerung rechtes Bein\\nINDENT 10/2010: Schub mit Dysästhesien der linken Körperhälfte sub Th 8 sowie des linken Oberarms, Hypästhesie des linken Unterschenkels, Fatigue\\nINDENT 08/2017 fraglich Schub mit Dysästhesien im linken Arm, Gesicht und Brustbereich, DD funktionell\\nINDENT 09/2020: neu aufgetretene leichtgradige zentrale Fazialisparese links mit Hypästhesie im V2-Bereich links sowie Hypästhesie digiti mani I u. II links.\\nINDENT Diagnostik:\\nINDENT 10/2009 Liquor: OKB positiv\\nINDENT 10/2009 MRI Gehirn: Multiple entzündliche Herde supra- und infratentoriell (davon neun akute entzündliche Läsionen) sowie akute Retrobulbärneuritis mit KM-Aufnahme re\\nINDENT 11/2009 MRI WS: zumindest 7 entzündliche Läsionen der Medulla spinalis\\nINDENT 02/2010 MRI Gehirn und WS: 7 neue, akut entzündliche Läsionen, davon 6 supratentoriell und eine spinal in Höhe HWK7/BWK1\\nINDENT 08/2010: Tysabri-Antikörper positiv\\nINDENT 01/2011 MRI Gehirn und WS: Kleinste aktive Läsionen im frontalen Zentrum semiovale rechts, im zervikalen Myelon im Bereich der Seitenstränge rechts, sowie Th12 in den Seitensträngen links.\\nINDENT 12/2012 MRI Gehirn und WS: Zwei neu aufgetretene demyelinisierende Läsionen im Bereich des linken Centrum semiovale, 2x KM-Aufnahme bereits bekannter Läsionen.\\nINDENT 11/2013 MRI Gehirn: Stationär zu 12/2012\\nINDENT 05/2014 MRI WS: Stationärer Befund zu 01/2011\\nINDENT 05/2014 MRI Gehirn: Mehrere grössenprogrediente und neu KM-aufnehmende Läsionen\\nINDENT 10/2014 MRI Gehirn: Neue Läsionen mit KM-Anreicherung im Gyrus parahippocampalis rechts sowie paraventrikulär aussen am rechten Temporalhorn \\nINDENT 11/2014 MRI WS: Neue KM-aufnehmende Läsion im posterolateralen Bereich des Myelons auf Höhe HWK2, neue nicht KM-aufnehmende Läsion im posterioren Funiculus auf Höhe BWK 8\\nINDENT 06/2015 MRI Gehirn: Neue KM-aufnehmende Läsionen paratrigonal bds. bzw. Übergang Corona radiata zum Zentrum semiovale rechts, sowie medial der Pyramide rechts\\nINDENT 11/2015 MRI Gehirn und WS: Gehirn stationär zu 06/2015, WS stationär zu 11/2014\\nINDENT cMRI 29.06.2017: 3 neue Läsionen, 2 davon mit leichter KM-Aufnahme, callosal rechts, paratrigonal links und im Centrum semiovale rechts\\nINDENT 02/2019: Zwei kleine zwischenzeitlich neu aufgetretene demyelinisierende Läsionen infratentoriell im Tegmentum mesencephali rechts, und im Funiculus posterior des mit abgebildeten Myelons auf Höhe HWK 1/2.\\nINDENT 08/2019 cMRI: stationärer Befund\\nINDENT 02/2020 MRI Neuroachse: keine neuen Läsionen\\nINDENT 09/2020 cMRI und HWS: Supratentoriell 4 neue Läsionen mit Schrankenstörung, die grösste Läsion findet sich im Gyrus precentralis rechts. Darüberhinaus supra- und infratentoriell je eine neu aufgetretene Läsion ohne Schrankenstörung sowie fraglich leicht progrediente Läsionen am Hinterhorn des rechten Seitenventrikels. Im zervikalen und oberen thorakalen Myelon mehrere unveränderte Herde aber keine neu Läsionen.\\nINDENT cMRI vom 03/2021:  stationäre ausgeprägte supra- und infratentorielle Läsionslast, eine neuen demyelinisierenden Läsionen.\\nINDENT sMRI vom 03/2021: stationär, keine neuen deymelinisierenden Läsionen.\\nINDENT Therapie:\\nINDENT 20.-22.10.09 SoluMedrol 1g über 3 Tage, 02/2010 Solu Medrol 1g i.v. über 4  Tage\\nINDENT 03/2010 - 07/2010 Tysabri (Natalizumab), Infusionsreaktion bei 2. und 3. Infusion, anaphylaktische Reaktion bei 5. Infusion mit konsekutivem Abbruch\\nINDENT 07/2010 - 11/2014 Copaxone, sistiert bei MR-morphologischer Progredienz\\nINDENT 12/2014 - 08/2015 Tecfidera, sistiert bei gastrointestinalen Nebenwirkungen\\nINDENT 08/2015 - 04/2017 Gilenya, sistiert wegen Kinderwunsch\\nINDENT Wiederbeginn mit Gilenya 10/2018 -> ca 2 Wochen Unterbruch 02/2020\\nINDENT 07.- 08.09.2020. SoluMedrol 1g i.v. 09.-11.09.2020 SoluMedrol 500 mg p.o.\\nINDENT geplante Therapie mit Ocrevus ab 05/2021[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose EM und ED 08/2018, EDSS 2.5\\nINDENT EDSS 01/2021: 2.5\\nINDENT anamnestisch: Fatigue, Konzetrationsstörung, Hypästhesie der rechten Körperhälfte (Oberkörper inkl. Gesicht), Temperature-Störung der linken Hände.\\nINDENT Diagnostik:\\nINDENT MRI Schädel 08/2018: Multiple supratentoriell Läsionen in einem für eine entzündlich demyelinisierende ZNS-Erkrankung typischen Verteilungsmuster, teils als \\'black holes\\' abgrenzbar ohne Zeichen einer Aktivität. 3/4 Barkhof-Kriterien erfüllt. \\nINDENT MRI HWS/BWS 09/2018: Zervikale Myelonläsion Höhe HWK 2/3 paramedian rechts mit pathologischer Kontrastmittelaufnahme, am ehesten einer aktiv-entzündlichen Läsion im Rahmen einer entzündlich demyelinisierenden ZNS-Erkrankung entsprechend\\nINDENT MRI Schädel und HWS 11/2018: Demyelinisierende Myelonläsion auf Höhe HWK 2/3 mit kompletter Rückbildung der Aktivität. Keine zwischenzeitlich neu aufgetretenen oder aktiven Läsionen intrakraniell oder im zervikalen Rückenmark.\\nINDENT MRI Schädel und HWS/BWS 02/2019: Stationär\\nINDENT MRI Schädel 01/2020: Stationär\\nINDENT MRI Schädel 01/2021: Stationär\\nINDENT Labor:\\nINDENT Liquor 08/2018: Zellzahl 3/µl, Totalprotein 628 mg/l,  IgG-Index 0.7, OKB positiv (Typ II)\\nINDENT Infektiologisches Screening 08/2018: HIV, HBV, HCV. Lues, Borrelien negativ\\nINDENT Immunologisches Screening 08/2018: ANA, RF, Anti-CCP, Anti-native DNA, Anti-SSA/B (Ro/La), Anti-Cardiolipin, ANCA negativ\\nINDENT JCV-Ak Test 09/2018: Positiv (Titer 0.37)\\nINDENT Therpaie:\\nINDENT St.n. Kortisonstoss 08/2018, 09/2018 sowie 11/2018\\nINDENT St.n. Plasmapherese 10/2018\\nINDENT Unter Gilenya seit 11/2018[/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nOphthalmologische Diagnose\\nOSMetall-Fremdkörper vom 11.04.2020[/INST]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\n1. Schubförmig-remittierende',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose, EM 06/2017, ED 07/2017, EDSS 1.0\\naktuell: klinisch nicht aktiv, radiologisch aktiv, keine Progression (nach Lublin et al. 2013)\\nAnamnestisch: \\naktuell keine Beschwerden\\nKlinisch: \\nunauffälliger neurologischer Befund\\nVerlauf: \\nAnfang 06/2017: Rezidivierende Kribbelparästhesien im rechten Bein. Nach Kortison im 07/2017 vollständige Regredienz.\\n03.07.2017: Schub mit Abduzensparese links. Nach Kortison vollständige Regredienz.\\n10/2018: Kribbelparästhesien und Hypästhsie (reduziertes Kältegefühl) der Oberschenkel (DD UAW auf Concerta)\\nDiagnostisch:\\nLabor\\n03.07.2017 Serologie: Nieren und Lebewerte sowie Blutbild unauffällig, BSG 16mm/h\\n06.07.2017 Liquor: Zellzahl 7/µl, Schrankenstörung, intrathekale IgG-Synthese, IgG-Index 0.64, Oligoklonale Banden im Liquor positiv, Serum negativ\\n06.07.2017: Serologie virologisches & bakteriologisches Screening: HIV, HBV, HCV neg. Treponema pallidum negativ, Borrelia burdorferi nicht reaktiv,  Immunologisches Screening negativ für: ANA, RF, Anti-CCP, Anti-native DNA, Anti-SSA/B (Ro/La), Anti-Cardiolipin, ANCA \\n07.07.2017 Labor: normgerechte Werte für Leber- und Nierenparameter, Elektrolyte, Folsäure, Vitamin B12, 25-Hydroxy Vitamin D, TSH, Holotranscobalamin, CRP\\nJCV-AK-Status vom 11/2018: negativ\\nBildgebung\\n05.07.2017 cMRI: multiple periverntrikuläre, juxtakortikale und infratentorielle T2-Läsionen, KM-Anreicherung im Nucleus abducens links, in root-entry-zone des N. trigeminus rechts\\n08.07.2017 spinales MRI: Läsionen auf Höhe C3/C4, Th2 und T12/S1, auf Höhe Th2 allenfalls mit flauen KM-Enhancement. Keine Spinalkanalstenose oder Nervenwurzelkompressionen\\ncMRI 04/2018: Neue demyelinisierende Marklagerläsionen supratentoriell im Centrum semiovale beidseits. Keine aktiven (kontrastmittelaufnehmenden) Läsionen.\\nMRI Neuroachse 10/2018: cerebral mehrere neue Läsionen, 3 davon mit KM-Aufnahme, spinal stabiler Befund\\nMRI Neuroachse 03/2019 rebaseline: Drei neue supratentorielle Marklagerläsionen rechtshemisphärisch und eine neue Myelonläsion in Höhe HWK 2, kein path. KM-Enhancement intrakraniell\\nTherapeutisch: \\n06.07-10.07.2017 orale Kortisonstosstherapie 1g über 5 Tage\\nAvonex 11/2017 - 11/2018\\n30.11.2019 Tysabri 300 mg / 4 Wochen[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmig verlaufende Multiple Sklerose (EM 10/2012), EDSS 1.0\\nAktuell: Intermittierende Parästhesien rechte Flanke, ohne Provokation (eher kein Lhermitte)\\nDiagnostisch:\\nINDENT - 01/13 Liquor (USZ): ZZ 10, Protein 564 mg/l, IgG 93.5 mg/l, IgG-Index 1.3,  Glukose normwertig, Laktat 2.8mmol/l. OKBs Positiv in Liquor und Serum.\\nLetzte Bildgebung: \\nINDENT - MRI spinal 04/14: Im Myelon: teils leicht regrediente, teils gering progrediente Läsionen, wobei eine Läsion links lateral auf Höhe BWK 6 nur fraglich eine vermehrte Kontrastmittelaufnahme aufweist, ansonsten kein Anhalt für KM-aufnehmende Läsionen.\\nINDENT - JCV-Ak-Test 02/14: negativ, Index 0.131\\nTherapie:\\nINDENT - Doxycyclin 400mg/d po für 10d ab 27.12.13 (in Schweden)\\nINDENT - 22.- 24.01.13 sowie 29.- 30.01.13 Solumedrol 1000 mg i.v. für 5 Tage\\nINDENT - 05.-09.02.13 Solumedrol 1000 mg i.v. für 5 Tage\\nINDENT - aktuell: Tysabri 300 mg i. v. alle 4 Wochen seit 03.09.13   [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose sekundär progredient mit überlagernden Schüben, EM 2005 ED 2006 EDSS 4.0\\naktuell: klinisch aktiv, radiologisch nicht aktiv, Progression ja (nach Lublin et al. 2013)\\nneu aufgetretene Sensibilitätsstörung linker Fuss seit Mitte Juni mit unvollständiger Rückbildung unter Cortison\\nVerlauf: \\nRetrobulbärneuritis im linken Auge 2005. \\ndrei Monate später (2005) in beiden Händen Sensibilitätsstörungen\\nerneut ca. drei Monate später Sensibilitätsstörungen der Zunge und der rechten Gesichtshälfte\\n2006 - 2009 stabiler Verlauf ohne Beschwerden\\nab 2009 Mühe mit Rennen, ab 2013 progrediente Gangstörung mit Spastik\\n12/16 fraglicher Schub mit Verschlechterung der Gangstörung, Cortisongabe in Italien\\n06/2019: Schub mit Hypästhesie des linken Fusses und zweimaliger Cortisonstosstherapie\\nDiagnostisch\\noligoklonale Banden im Liquor positiv, Aquaporin-4-AK negativ; immunologisches Screening bis auf unspezifisch erhöhte ANA (1:160) unauffällig\\nMRI Schädel und Wirbelsäule vom 01/17:  wenige Läsionen im Neurokranium, ausgedehnte Läsionen im Halsmark und untere BWS\\nMRI Gehirn 08/2017: Demyelinisierender Plaque auf Höhe der \\'root entry zone\\' des Nervus trigeminus rechts, vorbestehend. Insgesamt stationärer Befund \\nMRI Neuroachse 07/2018: stabiler Befund\\nMRI Neuroachse 07/2019: stabiler Befund\\ntherapeutisch:\\nRebif 09/2006- 2016 (aufgrund von Kopfschmerzen nach Einnahme abgesetzt)  \\nB-Zell-depletierende Therapie mit Rituximab empfohlen\\nGehäufte Exazerbationen einer bekannten Trigeminusneuropathie rechts mit Sensibliltätsstörung des linken Beins\\nätiologisch: demyelinisierende Plaque (i.R.v. Diagnose 2) auf Höhe der \\'root entry zone\\' des Nervus trigeminus rechts und Auslassung der Carbamazepinmedikation DD: zusätzlicher Gefäss-Nerv-Konflikt\\naktuell: kaum Beschwerden\\ndiagnostisch: \\nLabor vom 18.07.2018: Natrium 130, CK 378\\nEKG vom 18.07.2018: nc SR, ST, keine Erregungsrückbildungsstörungen\\ntherapeutisch im Verlauf: \\nPregabalin anamnestisch nur wenige Tage eingenommen wg. befürchteter Nebenwirkungen\\nCarbamazepin mit anamnestisch guter Wirkung, aber auch Nebenwirkungen wie Schwindel, Gangunsicherheit, Benommenheit\\nKeppra bislang nicht regelmässig eingenommen\\nAkutbehandlung bei Schmerzexazerbation mit insg. 100 mg Phenytoin i.v. am 25.10.2017\\nAkutbehandlung bei Schmerzexazerbation mit insg. 200 mg Phenytoin i.v. am 31.08.2017\\nAkutbehandlung bei Schmerzexazerbation mit insg. 100 mg Phenytoin i.v. am 27.06.2018\\nAkutbehandlung bei Schmerzexazerbation mit insg. 200 mg Phenytoin i.v. am 29.06.2018, ausserdem Wiederaufnahme von Carbamazepin, Lamotrigin (2x25mg/d) weiter\\nAkutbehandlung bei Schmerzexazerbation mit insg. 200 mg Phenytoin i.v. am 18.07.2018 [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose EM 07/2016, ED 08/2017, EDSS 4.0\\nAnamnestisch:\\nINDENT Keine Verbesserung nach 2x Kortisonstosstherapie. Weiterhin Verschwommensehen beidseits sowie Zunahme der Gangunsicherheit und der Kribbelparästhesien der Arme und Beine, residuell seit 07/2016 bekannte Kopfschmerzsymptomatik.\\nKlinisch: \\nINDENT Parese der Beine rechtsbetont mit Absinken im BVV bds., leichtgradige Parese des rechten Armes mit Absinken im AVV rechts. Kribbelparästhesien der Arme und Beine mit leichter Pallhypästhesie biradial und bimalleolär sowie weitestgehend fehlender Spitz-Stumpf-Diskrimination. Fallneigung nach rechts im Romberg-Versuch. Fernvisus bei 0,28 bds s.c.\\nVerlauf: \\nINDENT 07/2016: Neuritis nervi optici rechts.\\nINDENT 12/2017: Kopfschmerzen, verschwommenes Sehen, Schmerzen bei Augenbewegungen rechtsbetont. \\nINDENT 04/2017: Fraglicher Schub bei beidseitiger Visusminderung (re > li) mit Verschwommensehen über mehrere Monate ohne Farbentsättigung oder Augenmotilitätsstörungen\\nINDENT 09/2017: Schwindel mit Gangunsicherheit, fragl. Verschlechterung des Visus rechts\\nINDENT 10/2017: Schub mit Sehminderung auf dem linken Auge, retrobulbäre Schmerzsymptomatik, Zunahme der Gangunsicherheit, Parese im rechten Arm\\nDiagnostisch: \\nLabor\\nINDENT 07/2016 Infektiologisches Screening: Quantiferon-Test negativ, Lues negativ, Borrelia IgG nicht reaktiv, Borrelia IgM reaktiv, CMV negativ, HSV-1 negativ, HSV-2  negativ, Toxoplasmose negativ, VZV negativ, HIV negativ, Immunologisches Screening: ACE, ANCA-, Anti-Cardiolipin-, AQP4- und MOG-IgG negativ.\\nINDENT 0972016 Infektiologisches Screening: Borrelia unauffällig.\\nINDENT 07/2016 Liquor: 6 Zellen/µl, OKBs im Liquor positiv, Borrelien IgM/IgG im Liquor nicht reaktiv.\\nINDENT 08/2017 Quantiferon-Test: Tbc-Antigen-Test negativ.\\nBildgebung\\nINDENT 07/2016 cMRI: Am ehesten entzündliche Veränderung des Nervus opticus rechts. Zwei weitere Läsionen.\\nINDENT 11/2016 MRI cranial & spinal: Stationär, leichte degenerative Veränderungen LWK4/5 und LWK5/S1.\\nINDENT 04/2017 cMRI: Neue Läsionen in der Corona radiata beidseits, am Gyrus supramarginalis rechts mit perifokalem Ödem sowie am Gyrus frontalis inferior rechts. Weitere neue KM-aufnehmende  Läsionen. Spinal keine Läsionen oder KM-Aufnahmen.\\nINDENT 09/2017 cMRI: Progression der FLAIR hyperintensen Läsionen supra- und infratentoriell. Zwei neue KM-aufnehmende Läsionen links periventrikulär auf Höhe der Cella media sowie rechts zerebellär. \\nINDENT 10/2017 MRI (HWS und zerebral): Zerebral stationäre Läsionslast ohne KM-Aufnahme. Spinal kein Nachweis T2-hyperintenser Läsionen.\\nWeitere Untersuchungen:\\nINDENT 07/2016 Ophthalmologische Untersuchung: Fernvisus: Re: 0.6, li: 1.0, kein RAPD, keine Rotentsättigung.\\nINDENT 01/2017 Ophthalmologische Untersuchung: Fernvisus: Re: 0.6, li: 0.6, 06/2017 re: 1.0, li: 1.0. \\nINDENT 02/2017 OCT: Normwertige RNFL; 09/2017: links unauffällig, rechts minim reduziert. \\nINDENT 08/2017 Elektroretinogramm: Unauffällig.\\nINDENT 09/2017 OCT: Re. 0.46, li. 1.01.\\nINDENT 11/2017 OCT: Re. 0.46, li. 0.38.\\nTherapeutisch:  \\nINDENT Steroidpulstherapie 16.07.-20.07.2016.\\nINDENT Seit 30.08.2017: Therapie mit Aubagio.\\nINDENT Kortisonstosstherapie vom 28.09. - 02.10.2017 (1g i.v.).\\nINDENT Kortisonstosstherapie vom 07.11.-11.11.2017 (2g i.v.) mit Ausschleichen über 10 Tage (keine Besserung).\\nINDENT Plasmapheresetherapie vom 15.01.2018 bis zum 26.01.2018.[/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS) \\n',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nMultiple Sklerose (EM 05/2011, ED 09/2011)\\nINDENT aktuell:   EDSS 2.5 residuell gelegentlicher Schwankschwindel bei schnellen  Bewegungen und Lagewechseln.\\nINDENT Verlauf:\\nINDENT 05. 2011: Schub mit schleichendem Beginn im Mai 2011 mit Doppelbildern und Schwankschwindel, leichter Gangataxie, Kribbelparästhesien Dig V links. Deutliche Regredienz der Symptome auf Solumedrol (08/2011)\\nINDENT diagnostisch:\\nINDENT 10.8.11: VEP pds opB\\nINDENT 10.8.11 MRI Schädel: multiple entzündliche Läsionen juxtacortical, periventrikulär, infratentoriell, teils mit peripherem KM-Enhancement\\nINDENT 10.8.11 CT Thorax-Abdomen: keine AP für Tumor oder Entzündung\\nINDENT 10.8.11 Liquor: 7 Zellen/ul, mononukleär. IgGIndex 1.45, OKB positiv im Liquor, negativ im Serum. Im Reiberschema intrathekale IgG Synthese (kein IgA, kein IgM). \\nINDENT 10.8.11 intrathekale Ig-Bildung gegen Borrelia burgdorferi anzunehmen (im Immunoblot des Liquors IgG reaktiv, IgM negativ)\\nINDENT 18.8.11 MRI HWS, BWS, LWS: mutliple entzündlcihe Läsionen mit T2    Signalalteration auf Höhe HWK, BWK und LWK, keine KM-Anreicherung\\nINDENT Vorabklärung Fingolimod: VZV IgG pos., Leberwerte normal, kein Diabetes. Keine Arrhythmie, kein Maculaödem (Ophta 10.10.11), wenige Nävuszellnävi vom junktionalen Typ ohne Hinweise für Malignität (Derma 30.9.11) \\nINDENT 17.02.2012 MRI Schädel/spinal: Bekannte multiple MS-Läsionen supra- und infratentoriell mit 3 neuen Läsionen cerebral ohne KM-Anreicherung.\\nINDENT Therapie: \\nINDENT Solumedrol 1g über 3d (11.-13.08.), darunter klinisch deutliche \\nINDENT Regredienz \\nINDENT seit 31.10.2011 Gilenya 0.5mg p.o.tgl [/INST]\\nDiagnosis:\\nSchubförmig-remittierende Multiple Sklerose (RRMS)',\n",
       " '[INST]<<SYS>>\\nYou are a helpful, respectful and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature.\\n\\nIf a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don’t know the answer to a question, please don’t share false information.\\n<</SYS>>\\n\\nYour task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" and \"schubförmig remittierende Multiple Sklerose (RRMS)\".The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\" \"schubförmige remittierende Multiple Sklerose (RRMS)\", or \"not enough info\".To help you with your task, here are a few excerpts from reports that indiciate what output you should produce:\\n\\nReport:\\n1. Primär progrediente Multiple Sklerose, EM 1992, ED 1996, aktuell EDSS 7.0 [...]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)\\n\\nReport:\\n1. Sekundär progrediente schubförmige Multiple Sklerose [...]\\nDiagnosis:\\nSekundär progrediente Multiple Sklerose (SPMS)\\n\\nReport:\\nSchubförmig-remittierende Multiple Sklerose, EM 01/2013, ED 10/2015\\nINDENT EDSS 05/2020: 2.0 [...]\\nDiagnosis:\\nPrimär progrediente Multiple Sklerosis (PPMS)\\n\\nReport:\\n[...] INDENT MRI 07/2014: Progrediente supratentorielle MS-Plaques mit Befund-Progredienz im Bereich der Radiatio optica beidseits. [...]\\nDiagnosis:\\nnot enough info\\n\\nReport:\\nSchubförmige Multiple Sklerose (EM 07/2015, ED 01/2017)\\nINDENT EDSS Score Aktuell: 1.5\\nINDENT FS Scores: Visuell 0, Hirnstamm 1, Pyramidenbahn 0, zerebellär 0, sensibel 0, Miktion/Defäkation 0, zerebral 1, Gehstrecke: uneingeschränkt.\\nINDENT klinisch: aktuell: Faszikulationen in beiden Oberschenkeln, Müdigkeit, Schlafprobleme, leicht sakkadierte Augenfolge\\nINDENT Verlauf\\nINDENT 07/2015 Abducensparese links, INO rechts, verlangsamte horizontale und vertikale Sakkaden, Oszillopsien, Kribbelparästhesien alles Finger beidseits \\nINDENT 3/2016 intermittierend Kribbeln Fingerspitzen bds., keine Doppelbilder, dezente Abduzensparese links, leicht sakkadierte Augenfolge\\nINDENT 01/2017 Faszikulationen in beiden Oberschenkeln, Müdigkeit, leicht sakkadierte Augenfolge\\nINDENT Diagnostik: \\nINDENT cMRI 08/2015, Aarau: mehrere Marklagerherde in der T2-Wichtung, z.T.in juxtakortikale Position, eine infratentoirielle verteilung dorsal in der Pons. Keine KM Anreicherung\\nINDENT MRI 02/2016: Stationäre supra- und infratentorielle Läsionslast.  Keine KM Anreicherung\\nINDENT cMRI 19.8.2016 Neue demyelinisierende Läsion in der Pons paramedian links ohne Hinweis auf pathologische KM-Anreicherung. Restliche vorbeschriebene demyelinisierende Läsionen stationär \\nINDENT 02/2017 cMRI: 1 neue Läsion, kein Hinweis auf KM-aufnahme\\nINDENT Liquor (08/2015, Kanton Spital Aarau): normale Zellzahl (1), fragl. Oligoklonale IgG, Glukose, Gesamtprotein normwertig\\nINDENT JCV-Status 25.1.2017: negativ\\nINDENT Therapie: \\nINDENT Methylprednisolon 1000 mg/d 04.08-08.08.2015 [/INST]\\nDiagnosis:\\nSchubförmig remittierende Multiple Sklerose (RRMS)']"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "torch.load(paths.RESULTS_PATH/\"ms-diag\"/\"ms-diag_Llama2-MedTuned-13b_4bit_all_test_few_shot_vanilla.pt\", map_location=torch.device('cpu'))[\"whole_prompt\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "id": "8f7951f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.27      1.00      0.42         4\n",
      "           1       1.00      0.77      0.87        39\n",
      "           2       1.00      1.00      1.00         3\n",
      "           3       0.90      0.75      0.82        12\n",
      "\n",
      "    accuracy                           0.79        58\n",
      "   macro avg       0.79      0.88      0.78        58\n",
      "weighted avg       0.93      0.79      0.83        58\n",
      "\n"
     ]
    }
   ],
   "source": [
    "results = torch.load(paths.RESULTS_PATH/\"ms-diag/ms-diag_Llama2-MedTuned-13b_4bit_all_instruction_outlines\")\n",
    "print(classification_report(y_true=results[\"labels\"], y_pred=results[\"preds\"]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "id": "12a93ce6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model_answers</th>\n",
       "      <th>preds</th>\n",
       "      <th>exact_match</th>\n",
       "      <th>labels</th>\n",
       "      <th>rid</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>55E636B5-EA14-497D-832B-A87444F3C096</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM, ED 12/2005), EDSS 1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>CE90E38D-BBBF-4F7B-98E0-B87EE0E6DFCE</td>\n",
       "      <td>Schubförmige Multiple Sklerose, EM 05/2018, ED 07/2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>B0B07B18-0211-4467-8489-581AC761D297</td>\n",
       "      <td>Primär chronisch progrediente Multiple Sklerose, EM 2008, ED 2012, EDSS 4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>69273DEA-ACAC-40CD-8F02-840EB3CC2027</td>\n",
       "      <td>Schubförmig-remittierende Multiple Sklerose, EM und ED 04/2007\\nINDENT EDSS 05/2019: 2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>83D5B33F-2967-40C9-BA12-7173CF6C1BE0</td>\n",
       "      <td>Multiple Sklerose, schubförmiger Verlauf (EM 2006, ED 06.08.2014)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>745DA433-83BC-48B0-889D-9578F7F7C3D8</td>\n",
       "      <td>Primär chronisch progrediente Multiple Sklerose (PPMS), EM 03/2017, ED 08/2017, EDSS 6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>62278320-172E-4D59-AE84-4F28A2ED877D</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM und ED 05/2013), EDSS 2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>82C11DBE-09F4-4C2C-8F6F-B1D75BF9E790</td>\n",
       "      <td>Schubförmige multiple Sklerose (ED Januar 2013)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>9B962F57-AF41-42EE-B7B5-A99BFCDBEE51</td>\n",
       "      <td>V.a. primär progrediente Multiple Sklerose, EM 08/2016, ED 10/2018, EDSS 4.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>08F1FA27-6213-47AF-B967-DC44CCCE9613</td>\n",
       "      <td>Schubförmig remittierende Multiple Sklerose (EM 09/14), EDSS 0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>C545D8B8-9F4A-4628-B1DA-5F2FD64F1008</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 05/2015, ED 07/2015)\\nEDSS: 2.0 (Pyz: 1.0; Sens: 2.0; Cerebral/Fatigue: 2.0)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>22719E9F-BE4F-4C86-A728-EC6B1AF64B8F</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 04/2010, ED 06/2010), EDSS: 2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>D8FAC32E-FD14-4D4B-9F78-9A75D182E790</td>\n",
       "      <td>Schubförmige Multiple Sklerose (RRMS), EM 05/2003, ED 08/2003, EDSS 2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>66A52284-9258-4289-AB01-E02D652475B3</td>\n",
       "      <td>Schubförmige Multiple Sklerose (ES und ED 4/03, aktueller EDSS 0.0)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>B04CED97-2A0D-4B67-BBE4-1E262863FD29</td>\n",
       "      <td>Schubförmige Multiple Sklerose, EM 09/2020, ED 12/2020, EDSS 3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>AAE63006-727A-4DF6-82B7-32A86AB8F5C1</td>\n",
       "      <td>Schubförmige Multiple Sklerose\\nES 03, ED 10/2008 (gesichert nach McDonald Kriterien)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>95723A01-1885-482F-B580-9AD99B75D67D</td>\n",
       "      <td>Schubförmige Multiple Sklerose, EM 2000, ED 2014, EDSS 1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>C2232083-842D-42B2-A7DA-7D9EB4081C4B</td>\n",
       "      <td>Schubförmig verlaufende Multiple Sklerose, Erstmanifestation 10/2010, Erstdiagnose 02/2012 mit/bei:\\nINDENT EDSS 05/2017: 1.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>73F77600-044F-49F4-8541-0077D90A2869</td>\n",
       "      <td>Schubförmig remittierende Multiple Sklerose (RRMS), EDSS 2.0 (EM 1993, ED 2003)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>96BC21AA-235F-4EED-A74F-58EFC11C1176</td>\n",
       "      <td>Hochgradiger V.a. entzündliche ZNS-Erkrankung ED 03.05.2019, EM 30.04.2019\\nINDENT ätiologisch: möglicherweise multiple Sklerose</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>F87876FA-3068-4A93-AE71-6071CBE5F1F2</td>\n",
       "      <td>Entzündliche ZNS-Erkrankung, möglicherweise Multiple Sklerose vom schubförmig-remittierenden Verlaufstyp (ED 12/2015 Spital Linth)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>107AB593-34BD-4329-8A9A-D3584819FE50</td>\n",
       "      <td>Multiple Sklerose mit vorherrschend schubförmigem Verlauf: Ohne Angabe einer akuten Exazerbation oder Progression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>0</td>\n",
       "      <td>11A4453B-76B6-4558-8126-EEFEA6935C91</td>\n",
       "      <td>1. Multiple Sklerose a.e. primär progredient, EM 2011, ED 03/2015, EDSS 3.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>086D33C8-DDD3-4DE2-BFE0-A945076A2335</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 12/2009, ED 09/2010), aktueller EDSS 0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>D1529EA4-61AB-41D7-A98D-987F1B894F04</td>\n",
       "      <td>Schubförmig-remittierende Multiple Sklerose</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>1914ADB8-2E2D-4557-930E-4AB8422CBD5F</td>\n",
       "      <td>Vd.a. autoimmun-entzündliche ZNS-Ekrankung, am ehesten einer schubförmig-remittierenden multiplen Sklerose entsprechend (EM 1997):</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>F3C04A3C-D357-4F21-8146-21D9D81D8A70</td>\n",
       "      <td>Schubförmige Multiple Sklerose, EM 5/2015, ED 1/2016, EDSS 1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>659D3D0B-AD43-43D4-A99A-34891BA3B676</td>\n",
       "      <td>Schubförmige Multiple Sklerose, ED 07/2016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>ABF47F0B-D5E3-46A7-B506-1B961357E158</td>\n",
       "      <td>Chronisch-demyelinisierende ZNS-Erkrankung, EM 01/2016, ED 02/2018\\nINDENT ätiologisch: a.e. schubförmige Multiple Sklerose (McDonald Kriterien 2010 erfüllt, Ausschlussdiagnostik noch nicht komplettiert)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>CD1C0F8D-21C7-4E03-B64E-AD434E7CCB0C</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 12/2006, ED 06/2015), EDSS 3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>E71ECC99-2B1A-4061-BDC3-F5FBC039DBC9</td>\n",
       "      <td>Schubförmige Multiple Sklerose mit Residuen, EM 2000, ED 2006, EDSS 6.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>ED59D138-BDFC-4928-BE49-FE6FCBD6CA80</td>\n",
       "      <td>Multiple Sklerose, schubförmige Verlaufsform (EM 03/2015, ED 05/2015), EDSS 1.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>2</td>\n",
       "      <td>E81AD81E-7504-4FFE-AA11-77E288E77CEC</td>\n",
       "      <td>Multiple Sklerose mit sekundär progredientem Verlauf seit ca. 2004 (EM 1983, ED 1996)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>54FBE2C1-4F4A-4E43-AD9B-CF5774675F73</td>\n",
       "      <td>INDENT Multiple Sklerose, schubförmiger Verlauf mit Residuen (ED: 9/2004)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>BF7EA6DC-B4E8-429B-9477-2E6B2BCFAD1F</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 2002?/12/2004, ED 5/2009)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>2</td>\n",
       "      <td>763EC115-4945-4536-A788-A1CC7B8A6A79</td>\n",
       "      <td>Sekundär progrediente Multiple Sklerose (EM 1998, ED 1999), EDSS 7.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>1B0FEA22-621B-4D5D-A42B-D0E53FD1AECD</td>\n",
       "      <td>Schubförmige Multiple Sklerose (ED 01/2013), EDSS 0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>DAFCC9D2-BC06-41A2-B2D6-10666960B6AE</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 11/13, ED 1/2017) EDSS 1.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>BE04513F-6108-4398-926A-724146897A64</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM vermutlich 2007; ED 10/09), EDSS 2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>9CDC9099-BD34-4034-BD1B-D7D89FA834C3</td>\n",
       "      <td>Schubförmige Multiple Sklerose EM und ED 08/2018, EDSS 2.5\\nINDENT EDSS 01/2021: 2.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>7F04C42B-213B-4C1D-923F-62501A34D7D0</td>\n",
       "      <td>Schubförmige Multiple Sklerose, EM 06/2017, ED 07/2017, EDSS 1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>A626A462-072B-42B2-99E4-2760BDDD7EFA</td>\n",
       "      <td>Schubförmig verlaufende Multiple Sklerose (EM 10/2012), EDSS 1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>2</td>\n",
       "      <td>786DE63D-D0A9-4380-9BD6-3E5EF553376A</td>\n",
       "      <td>Multiple Sklerose sekundär progredient mit überlagernden Schüben, EM 2005 ED 2006 EDSS 4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>0BFA6719-5A63-4C72-95CB-83129A21B53D</td>\n",
       "      <td>Schubförmige Multiple Sklerose EM 07/2016, ED 08/2017, EDSS 4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>other</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>B5B6D014-7E02-44E5-8390-F571F7C1D4E5</td>\n",
       "      <td>Multiple Sklerose (EM 05/2011, ED 09/2011)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>primär progrediente Multiple Sklerose</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>55B027BE-6029-4739-A21F-97B4E9A8E564</td>\n",
       "      <td>Schubförmige Multiple Sklerose (EM 07/2015, ED 01/2017)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>3936CA3D-B5C4-4A96-A444-12E063E179D6</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>E9941152-A80C-413D-8932-EFD653518645</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>A3141CEA-1444-4DDC-955F-12149A7BBFB9</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>724D9DC7-B8D8-4764-835B-63D7421DF668</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>DFC51E69-4E29-467F-AF71-BBFE79F6778D</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>55B54D22-681F-45AC-B7B6-0D9725251348</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>1ED19CB8-D11F-483B-ACC5-932BED8C5430</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>8133EA4C-EFDF-4ECC-85E8-9DAFC9AA2886</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>7D7D9BA6-4AE6-4CD2-BDC9-798749B65DBC</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>B7A45A46-3C7A-4BAD-9C4D-4214319D9165</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>3B531388-5110-46A8-BF79-AAE81B45974C</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>no information found</td>\n",
       "      <td>3</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "      <td>796CEAE8-80F8-4D41-A409-422214ED4FF6</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            model_answers  preds  exact_match  labels                                   rid                                                                                                                                                                                                         text\n",
       "0   primär progrediente Multiple Sklerose      0         True       1  55E636B5-EA14-497D-832B-A87444F3C096                                                                                                                                                    Schubförmige Multiple Sklerose (EM, ED 12/2005), EDSS 1.0\n",
       "1                                   other      3         True       1  CE90E38D-BBBF-4F7B-98E0-B87EE0E6DFCE                                                                                                                                                       Schubförmige Multiple Sklerose, EM 05/2018, ED 07/2018\n",
       "2   primär progrediente Multiple Sklerose      0         True       0  B0B07B18-0211-4467-8489-581AC761D297                                                                                                                                  Primär chronisch progrediente Multiple Sklerose, EM 2008, ED 2012, EDSS 4.0\n",
       "3                                   other      3         True       1  69273DEA-ACAC-40CD-8F02-840EB3CC2027                                                                                                                     Schubförmig-remittierende Multiple Sklerose, EM und ED 04/2007\\nINDENT EDSS 05/2019: 2.0\n",
       "4                                   other      3         True       1  83D5B33F-2967-40C9-BA12-7173CF6C1BE0                                                                                                                                            Multiple Sklerose, schubförmiger Verlauf (EM 2006, ED 06.08.2014)\n",
       "5   primär progrediente Multiple Sklerose      0         True       0  745DA433-83BC-48B0-889D-9578F7F7C3D8                                                                                                                     Primär chronisch progrediente Multiple Sklerose (PPMS), EM 03/2017, ED 08/2017, EDSS 6.0\n",
       "6                                   other      3         True       1  62278320-172E-4D59-AE84-4F28A2ED877D                                                                                                                                                 Schubförmige Multiple Sklerose (EM und ED 05/2013), EDSS 2.0\n",
       "7                                   other      3         True       1  82C11DBE-09F4-4C2C-8F6F-B1D75BF9E790                                                                                                                                                              Schubförmige multiple Sklerose (ED Januar 2013)\n",
       "8   primär progrediente Multiple Sklerose      0         True       0  9B962F57-AF41-42EE-B7B5-A99BFCDBEE51                                                                                                                                 V.a. primär progrediente Multiple Sklerose, EM 08/2016, ED 10/2018, EDSS 4.5\n",
       "9   primär progrediente Multiple Sklerose      0         True       1  08F1FA27-6213-47AF-B967-DC44CCCE9613                                                                                                                                             Schubförmig remittierende Multiple Sklerose (EM 09/14), EDSS 0.0\n",
       "10                                  other      3         True       1  C545D8B8-9F4A-4628-B1DA-5F2FD64F1008                                                                                              Schubförmige Multiple Sklerose (EM 05/2015, ED 07/2015)\\nEDSS: 2.0 (Pyz: 1.0; Sens: 2.0; Cerebral/Fatigue: 2.0)\n",
       "11                                  other      3         True       1  22719E9F-BE4F-4C86-A728-EC6B1AF64B8F                                                                                                                                           Schubförmige Multiple Sklerose (EM 04/2010, ED 06/2010), EDSS: 2.0\n",
       "12                                  other      3         True       1  D8FAC32E-FD14-4D4B-9F78-9A75D182E790                                                                                                                                     Schubförmige Multiple Sklerose (RRMS), EM 05/2003, ED 08/2003, EDSS 2.0 \n",
       "13                                  other      3         True       1  66A52284-9258-4289-AB01-E02D652475B3                                                                                                                                          Schubförmige Multiple Sklerose (ES und ED 4/03, aktueller EDSS 0.0)\n",
       "14                                  other      3         True       1  B04CED97-2A0D-4B67-BBE4-1E262863FD29                                                                                                                                            Schubförmige Multiple Sklerose, EM 09/2020, ED 12/2020, EDSS 3.0 \n",
       "15  primär progrediente Multiple Sklerose      0         True       1  AAE63006-727A-4DF6-82B7-32A86AB8F5C1                                                                                                                        Schubförmige Multiple Sklerose\\nES 03, ED 10/2008 (gesichert nach McDonald Kriterien)\n",
       "16                                  other      3         True       1  95723A01-1885-482F-B580-9AD99B75D67D                                                                                                                                                   Schubförmige Multiple Sklerose, EM 2000, ED 2014, EDSS 1.0\n",
       "17                                  other      3         True       1  C2232083-842D-42B2-A7DA-7D9EB4081C4B                                                                                Schubförmig verlaufende Multiple Sklerose, Erstmanifestation 10/2010, Erstdiagnose 02/2012 mit/bei:\\nINDENT EDSS 05/2017: 1.5\n",
       "18                                  other      3         True       1  73F77600-044F-49F4-8541-0077D90A2869                                                                                                                              Schubförmig remittierende Multiple Sklerose (RRMS), EDSS 2.0 (EM 1993, ED 2003)\n",
       "19                                  other      3         True       1  96BC21AA-235F-4EED-A74F-58EFC11C1176                                                                             Hochgradiger V.a. entzündliche ZNS-Erkrankung ED 03.05.2019, EM 30.04.2019\\nINDENT ätiologisch: möglicherweise multiple Sklerose\n",
       "20                                  other      3         True       1  F87876FA-3068-4A93-AE71-6071CBE5F1F2                                                                           Entzündliche ZNS-Erkrankung, möglicherweise Multiple Sklerose vom schubförmig-remittierenden Verlaufstyp (ED 12/2015 Spital Linth)\n",
       "21                                  other      3         True       1  107AB593-34BD-4329-8A9A-D3584819FE50                                                                                            Multiple Sklerose mit vorherrschend schubförmigem Verlauf: Ohne Angabe einer akuten Exazerbation oder Progression\n",
       "22                                  other      3         True       0  11A4453B-76B6-4558-8126-EEFEA6935C91                                                                                                                                  1. Multiple Sklerose a.e. primär progredient, EM 2011, ED 03/2015, EDSS 3.5\n",
       "23                                  other      3         True       1  086D33C8-DDD3-4DE2-BFE0-A945076A2335                                                                                                                                    Schubförmige Multiple Sklerose (EM 12/2009, ED 09/2010), aktueller EDSS 0\n",
       "24                                  other      3         True       1  D1529EA4-61AB-41D7-A98D-987F1B894F04                                                                                                                                                                 Schubförmig-remittierende Multiple Sklerose \n",
       "25                                  other      3         True       1  1914ADB8-2E2D-4557-930E-4AB8422CBD5F                                                                           Vd.a. autoimmun-entzündliche ZNS-Ekrankung, am ehesten einer schubförmig-remittierenden multiplen Sklerose entsprechend (EM 1997):\n",
       "26                                  other      3         True       1  F3C04A3C-D357-4F21-8146-21D9D81D8A70                                                                                                                                               Schubförmige Multiple Sklerose, EM 5/2015, ED 1/2016, EDSS 1.0\n",
       "27                                  other      3         True       1  659D3D0B-AD43-43D4-A99A-34891BA3B676                                                                                                                                                                   Schubförmige Multiple Sklerose, ED 07/2016\n",
       "28                                  other      3         True       1  ABF47F0B-D5E3-46A7-B506-1B961357E158  Chronisch-demyelinisierende ZNS-Erkrankung, EM 01/2016, ED 02/2018\\nINDENT ätiologisch: a.e. schubförmige Multiple Sklerose (McDonald Kriterien 2010 erfüllt, Ausschlussdiagnostik noch nicht komplettiert)\n",
       "29                                  other      3         True       1  CD1C0F8D-21C7-4E03-B64E-AD434E7CCB0C                                                                                                                                            Schubförmige Multiple Sklerose (EM 12/2006, ED 06/2015), EDSS 3.0\n",
       "30                                  other      3         True       1  E71ECC99-2B1A-4061-BDC3-F5FBC039DBC9                                                                                                                                      Schubförmige Multiple Sklerose mit Residuen, EM 2000, ED 2006, EDSS 6.5\n",
       "31                                  other      3         True       1  ED59D138-BDFC-4928-BE49-FE6FCBD6CA80                                                                                                                              Multiple Sklerose, schubförmige Verlaufsform (EM 03/2015, ED 05/2015), EDSS 1.5\n",
       "32                                  other      3         True       2  E81AD81E-7504-4FFE-AA11-77E288E77CEC                                                                                                                        Multiple Sklerose mit sekundär progredientem Verlauf seit ca. 2004 (EM 1983, ED 1996)\n",
       "33                                  other      3         True       1  54FBE2C1-4F4A-4E43-AD9B-CF5774675F73                                                                                                                                    INDENT Multiple Sklerose, schubförmiger Verlauf mit Residuen (ED: 9/2004)\n",
       "34                                  other      3         True       1  BF7EA6DC-B4E8-429B-9477-2E6B2BCFAD1F                                                                                                                                                 Schubförmige Multiple Sklerose (EM 2002?/12/2004, ED 5/2009)\n",
       "35                                  other      3         True       2  763EC115-4945-4536-A788-A1CC7B8A6A79                                                                                                                                         Sekundär progrediente Multiple Sklerose (EM 1998, ED 1999), EDSS 7.0\n",
       "36                                  other      3         True       1  1B0FEA22-621B-4D5D-A42B-D0E53FD1AECD                                                                                                                                                          Schubförmige Multiple Sklerose (ED 01/2013), EDSS 0\n",
       "37                                  other      3         True       1  DAFCC9D2-BC06-41A2-B2D6-10666960B6AE                                                                                                                                                Schubförmige Multiple Sklerose (EM 11/13, ED 1/2017) EDSS 1.5\n",
       "38                                  other      3         True       1  BE04513F-6108-4398-926A-724146897A64                                                                                                                                      Schubförmige Multiple Sklerose (EM vermutlich 2007; ED 10/09), EDSS 2.0\n",
       "39                                  other      3         True       1  9CDC9099-BD34-4034-BD1B-D7D89FA834C3                                                                                                                         Schubförmige Multiple Sklerose EM und ED 08/2018, EDSS 2.5\\nINDENT EDSS 01/2021: 2.5\n",
       "40                                  other      3         True       1  7F04C42B-213B-4C1D-923F-62501A34D7D0                                                                                                                                             Schubförmige Multiple Sklerose, EM 06/2017, ED 07/2017, EDSS 1.0\n",
       "41                                  other      3         True       1  A626A462-072B-42B2-99E4-2760BDDD7EFA                                                                                                                                             Schubförmig verlaufende Multiple Sklerose (EM 10/2012), EDSS 1.0\n",
       "42                                  other      3         True       2  786DE63D-D0A9-4380-9BD6-3E5EF553376A                                                                                                                   Multiple Sklerose sekundär progredient mit überlagernden Schüben, EM 2005 ED 2006 EDSS 4.0\n",
       "43                                  other      3         True       1  0BFA6719-5A63-4C72-95CB-83129A21B53D                                                                                                                                              Schubförmige Multiple Sklerose EM 07/2016, ED 08/2017, EDSS 4.0\n",
       "44                                  other      3         True       1  B5B6D014-7E02-44E5-8390-F571F7C1D4E5                                                                                                                                                                   Multiple Sklerose (EM 05/2011, ED 09/2011)\n",
       "45  primär progrediente Multiple Sklerose      0         True       1  55B027BE-6029-4739-A21F-97B4E9A8E564                                                                                                                                                      Schubförmige Multiple Sklerose (EM 07/2015, ED 01/2017)\n",
       "46                   no information found      3         True       3  3936CA3D-B5C4-4A96-A444-12E063E179D6                                                                                                                                                                                                             \n",
       "47                   no information found      3         True       3  E9941152-A80C-413D-8932-EFD653518645                                                                                                                                                                                                             \n",
       "48                   no information found      3         True       3  A3141CEA-1444-4DDC-955F-12149A7BBFB9                                                                                                                                                                                                             \n",
       "49                   no information found      3         True       3  724D9DC7-B8D8-4764-835B-63D7421DF668                                                                                                                                                                                                             \n",
       "50                   no information found      3         True       3  DFC51E69-4E29-467F-AF71-BBFE79F6778D                                                                                                                                                                                                             \n",
       "51                   no information found      3         True       3  55B54D22-681F-45AC-B7B6-0D9725251348                                                                                                                                                                                                             \n",
       "52                   no information found      3         True       3  1ED19CB8-D11F-483B-ACC5-932BED8C5430                                                                                                                                                                                                             \n",
       "53                   no information found      3         True       3  8133EA4C-EFDF-4ECC-85E8-9DAFC9AA2886                                                                                                                                                                                                             \n",
       "54                   no information found      3         True       3  7D7D9BA6-4AE6-4CD2-BDC9-798749B65DBC                                                                                                                                                                                                             \n",
       "55                   no information found      3         True       3  B7A45A46-3C7A-4BAD-9C4D-4214319D9165                                                                                                                                                                                                             \n",
       "56                   no information found      3         True       3  3B531388-5110-46A8-BF79-AAE81B45974C                                                                                                                                                                                                             \n",
       "57                   no information found      3         True       3  796CEAE8-80F8-4D41-A409-422214ED4FF6                                                                                                                                                                                                             "
      ]
     },
     "execution_count": 112,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "load_results(\"ms-diag_outlines_Llama2-MedTuned-7b_4bit_all_test_few_shot_vanilla_rag.pt\", labels=\"label_encodings_Llama2-MedTuned-7b.pt\", load_line=False, load_outlines=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9b0460d9",
   "metadata": {},
   "source": [
    "## Prompting Base"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "98ee374c",
   "metadata": {},
   "source": [
    "## Prompting RAG"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2eae3967",
   "metadata": {},
   "source": [
    "## Prompting Outlines"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f9a7d3ef",
   "metadata": {},
   "source": [
    "## Prompting RAG + Outlines"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "92ff1373",
   "metadata": {},
   "source": [
    "## Zero Shot\n",
    "\n",
    "Following an instruction tuning approach, as the MedTuned model was finetuned using an instruction dataset (Rohanian et al. 2023). The template looks as follows:\n",
    "\n",
    "```python\n",
    "\"<s>[INST]### Instruction: {instruction} ### Input: {user_input} ### Output: [/INST]\"\n",
    "```\n",
    "instruction:\n",
    "\"Your task is to extract the type of multiple Sclerosis (MS) stated in a German medical report. There are 3 types: \"primär progrediente Multiple Sklerose (PPMS), sekundär progrediente Multiple Sklerose (SPMS) and schubförmige Multiple Sklerose (RRMS). The type is provided in the text you just have to extract it. If you cannot match a type exactly answer with \"not enough info\".Your answer should solely consist of either \"primär progrediente Multiple Sklerose (PPMS)\", \"sekundär progrediente Multiple Sklerose (SPMS)\", \"schubförmige Multiple Sklerose (RRMS)\", or \"not enough info. Here is the medical report: \"\n",
    "\n",
    "user_input: the medical report to be processed\n",
    "\n",
    "I will compare single line classification, full report classification and a variation of full report classification putting the diagnosis last.\n",
    "                   "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e5663ec6",
   "metadata": {},
   "source": [
    "### Line-Level"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "528c639d",
   "metadata": {},
   "outputs": [],
   "source": [
    "results_line = pd.read_csv(paths.RESULTS_PATH/\"ms-diag/ms-diag_llama2-MedTuned_clm_line_paper-prompt_all.csv\", index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "64b0d858",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Count of how many do not explicitly follow the desired output format, I will allow for lowercase and strip\n",
    "allowed_fomats = [\"primär progrediente multiple sklerose (ppms)\", \n",
    "                  \"sekundär progrediente multiple sklerose (spms)\",\n",
    "                  \"schubförmige multiple sklerose (rrms)\"]\n",
    "\n",
    "# Function to check for exact matches\n",
    "def check_exact_match(series, allowed_formats):\n",
    "    \"\"\"\n",
    "    Check if each value in the Pandas Series exactly matches one of the allowed formats.\n",
    "\n",
    "    Parameters:\n",
    "    - series: Pandas Series\n",
    "    - allowed_formats: List of allowed formats\n",
    "\n",
    "    Returns:\n",
    "    - A boolean mask indicating whether each value exactly matches one of the allowed formats.\n",
    "    \"\"\"\n",
    "    return series.apply(lambda x: any(str(x).lower() == allowed_format.lower() for allowed_format in allowed_formats))\n",
    "\n",
    "# Remapping it to labels using keyword mapping\n",
    "label_mapping = {\n",
    "    'ppms': 'primary_progressive_multiple_sclerosis',\n",
    "    'primär': 'primary_progressive_multiple_sclerosis',\n",
    "    'sekundär': 'secondary_progressive_multiple_sclerosis',\n",
    "    'spms': 'secondary_progressive_multiple_sclerosis',\n",
    "    'rrms': 'relapsing_remitting_multiple_sclerosis',\n",
    "    'schubförmig': 'relapsing_remitting_multiple_sclerosis',\n",
    "    'not enough info': 'no_ms'\n",
    "}\n",
    "\n",
    "def map_strings_to_labels(input_string):\n",
    "    \"\"\"\n",
    "    Map a string to a label using a keyword mapping. If more than one keyword is found, the first one is used.\n",
    "\n",
    "    Parameters:\n",
    "    - input_string: String to map to a label\n",
    "\n",
    "    Returns:\n",
    "    - The mapped label\n",
    "    \"\"\"\n",
    "    \n",
    "    input_lower = str(input_string).strip().lower()\n",
    "    \n",
    "    first_match_key = None\n",
    "    first_match_index = float('inf')  # Set to positive infinity initially\n",
    "    \n",
    "    for key in label_mapping.keys():\n",
    "        index = input_lower.find(key)\n",
    "        if index != -1 and index < first_match_index:\n",
    "            first_match_key = key\n",
    "            first_match_index = index\n",
    "    label = label_mapping.get(first_match_key, None) if first_match_key else None\n",
    "    return ms_label2id.get(label, -99)\n",
    "\n",
    "def zero_shot_report(file_name):\n",
    "    \"\"\"\n",
    "    Print a report for the zero-shot classification task.\n",
    "\n",
    "    Parameters:\n",
    "    - results: File name of the results file. Must have columns \"labels\" and \"result\".\n",
    "    \"\"\"\n",
    "\n",
    "    results = pd.read_csv(paths.RESULTS_PATH/\"ms-diag\"/file_name, index_col=0)\n",
    "    \n",
    "    # Cast result column to string\n",
    "    results.result = results.result.astype(str)\n",
    "\n",
    "    # Exact match\n",
    "    exact_match = check_exact_match(results.result, allowed_fomats)\n",
    "    print(\"Exact match percentage: \", sum(exact_match)/len(results))\n",
    "\n",
    "    # Remap to labels\n",
    "    results.preds = results.result.apply(map_strings_to_labels)\n",
    "    print(\"No matches: \", sum(results.preds==-99))\n",
    "\n",
    "    # Print classification report\n",
    "    print(classification_report(y_true=results.labels, y_pred=results.preds, target_names=[\"no_match\"] + list(ms_label2id.keys())))\n",
    "\n",
    "    # Plot confusion matrix\n",
    "    plot_confusion_matrix(labels=results.labels, preds=results.preds)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "9a2bd545",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Exact match percentage:  0.08552817898612292\n",
      "No matches:  192\n",
      "                                          precision    recall  f1-score   support\n",
      "\n",
      "                                no_match       0.00      0.00      0.00         0\n",
      "  primary_progressive_multiple_sclerosis       0.02      1.00      0.04        13\n",
      "  relapsing_remitting_multiple_sclerosis       0.82      0.89      0.86       131\n",
      "secondary_progressive_multiple_sclerosis       0.62      1.00      0.76         8\n",
      "                                   no_ms       1.00      0.76      0.86      3379\n",
      "\n",
      "                                accuracy                           0.76      3531\n",
      "                               macro avg       0.49      0.73      0.50      3531\n",
      "                            weighted avg       0.99      0.76      0.86      3531\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "zero_shot_report(\"ms-diag_llama2-MedTuned_clm_line_paper-prompt_all.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "09bf185a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Exact match percentage:  0.46113989637305697\n",
      "No matches:  1\n",
      "                                          precision    recall  f1-score   support\n",
      "\n",
      "                                no_match       0.00      0.00      0.00         0\n",
      "  primary_progressive_multiple_sclerosis       0.32      1.00      0.48        13\n",
      "  relapsing_remitting_multiple_sclerosis       0.99      0.77      0.87       131\n",
      "secondary_progressive_multiple_sclerosis       0.67      0.50      0.57         8\n",
      "                                   no_ms       0.86      0.90      0.88        41\n",
      "\n",
      "                                accuracy                           0.80       193\n",
      "                               macro avg       0.57      0.63      0.56       193\n",
      "                            weighted avg       0.90      0.80      0.83       193\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "zero_shot_report(\"ms-diag_llama2-MedTuned_clm_all_paper-prompt_all.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a08fe2a3",
   "metadata": {},
   "source": [
    "The difference in exact matches is because there are not as many reports, and especially not as many \"no-info\" reports."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "3a2f4b05",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Exact match percentage:  0.5181347150259067\n",
      "No matches:  3\n",
      "                                          precision    recall  f1-score   support\n",
      "\n",
      "                                no_match       0.00      0.00      0.00         0\n",
      "  primary_progressive_multiple_sclerosis       0.33      0.92      0.49        13\n",
      "  relapsing_remitting_multiple_sclerosis       0.99      0.84      0.91       131\n",
      "secondary_progressive_multiple_sclerosis       0.57      0.50      0.53         8\n",
      "                                   no_ms       0.92      0.80      0.86        41\n",
      "\n",
      "                                accuracy                           0.82       193\n",
      "                               macro avg       0.56      0.61      0.56       193\n",
      "                            weighted avg       0.91      0.82      0.85       193\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n",
      "/home/ubuntu/anaconda3/envs/inf-extr/lib/python3.9/site-packages/sklearn/metrics/_classification.py:1469: UndefinedMetricWarning: Recall and F-score are ill-defined and being set to 0.0 in labels with no true samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, msg_start, len(result))\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "zero_shot_report(\"ms-diag_llama2-MedTuned_clm_first-last_paper-prompt_all.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f24fd2e",
   "metadata": {},
   "source": [
    "### Intermezzo: Sequence length and accuracy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "a85c636e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[-0.00029437]]\n"
     ]
    }
   ],
   "source": [
    "# Log regression to find out input len and probability of correct classification\n",
    "results_all = pd.read_csv(paths.RESULTS_PATH/\"ms-diag\"/\"ms-diag_llama2-MedTuned_clm_all_paper-prompt_all.csv\", index_col=0)\n",
    "y = (results_all.labels == results_all.preds).astype(int)\n",
    "X = results_all.input_len\n",
    "\n",
    "from sklearn.linear_model import LogisticRegression\n",
    "\n",
    "clf = LogisticRegression(random_state=0).fit(X.values.reshape(-1, 1), y.values)\n",
    "\n",
    "print(clf.coef_)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
